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Abstract 
Lung cancer is the leading cause of cancer related deaths worldwide. Cancer is caused by an 
accumulation of genetic and epigenetic changes that leads to alterations in gene activity and 
phenotype. There is emerging evidence of the epigenetic events in initiation and progression 
of cancer. Tobacco smoking is the major cause of lung cancer, involving numerous 
carcinogens. An in vitro transformation model had previously been established at STAMI, 
where human bronchial epithelial cells (HBECs) were exposed to tobacco smoke carcinogens 
(benzo[a]pyrene, cigarette smoke condensate and N-methylnitrosourea) for up to 15 weeks. 
Two transformed cell lines (HBEC-2KT and HBEC-12KT) were used as models to 
investigate molecular changes associated with transformation. The first aim of this thesis was 
to investigate how transformation affected cell migration. The second aim was to investigate 
whether DNA methylation of FOXA1 and FOXA2 genes could explain their downregulation 
in transformed cells relative to non-transformed cells. 
 
Two methods, the manual in vitro scratch assay and a semi-automated technique using 
IncuCyte ZOOM, were used to study cell migration. Both methods involve creating a wound 
in the cell monolayer and further measure the cells migration into the wound during a set time 
period. Light microscope images were acquired after 0 and 12 hours for the manual method, 
and on an hourly basis for 24 hours for the semi-automated method. DNA methylation studies 
were carried out by bisulfite treatment of DNA followed by pyrosequencing. 
 
Transformed HBEC-12KT showed decreased migration compared to their control cells 
(DMSO). HBEC-2KT transformed cells also showed decreased migration compared to their 
control cells (DMSO) when analysed by IncuCyte ZOOM. However, an increased migration 
was observed when transformed HBEC-2KT were analysed by in vitro scratch assay. 
Previous gene expression analysis of transformed cell lines showed reduced expression of E-
cadherin (CDH1) and increased expression of N-cadherin (CDH2), which indicates a 
hallmark of EMT known as the cadherin switch. This was supported by downregulation of the 
FOXA1 and FOXA2 genes, which may be an essential step of EMT in cancer progression.  
 
DNA methylation levels in the FOXA1_pyro1 assay varied between 35-90 % in both 
transformed HBEC-2KT and their control cells (DMSO). DNA methylation levels in this 
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assay were above 90 % in both transformed HBEC-12KT and their control cells (DMSO). 
DNA methylation levels in the FOXA1_pyro2 assay were above 80 % in transformed HBEC-
2KT and their control cells (DMSO), and above 70 % in transformed HBEC-12KT and their 
control cells (DMSO). Therefore, it is difficult to draw conclusions on whether methylation of 
FOXA1 is related to its expression since non-transformed cells already had high methylation 
levels in the studied CpG sites. In addition, it might be speculated that the inspected sites are 
not involved in gene silencing since control cells express the gene despite high levels of 
methylation. 
 
Both FOXA2 assays showed overall lower DNA methylation levels than the FOXA1 assays. 
In the FOXA2_cpg1 assay the DNA methylation levels were below 10 % in all of the 
transformed cell lines (HBEC-2KT and HBEC-12KT), and also their control cells (DMSO). 
Methylation levels in FOXA2_TSS ranged between 0-50 % for transformed HBEC-2KT and 
their control cells (DMSO). The majority of the transformed HBEC-12KT cells showed DNA 
methylation levels between 20-50 % in the FOXA2_TSS assay. Their control cells (DMSO) 
also showed DNA methylation levels in the same range. Thus, downregulation of FOXA2 
gene expression in transformed cell lines was in contrast to an overall low degree of DNA 
methylation and no outstanding changes in DNA methylation levels between non-transformed 
and transformed cell lines were observed. 
 
In conclusion, changes in migration between transformed and non-transformed cell lines were 
observed. It is, however, clear that cell migration and EMT are not directly linked in this in 
vitro transformation model. Based on bisulfite/pyrosequencing analyses, no outstanding 
changes in DNA methylation of the CpG sites studied between non-transformed and 
transformed cells were observed. Hence, based on the results presented in this thesis, no 
conclusions can be drawn to whether downregulation of FOXA1 and FOXA2 gene expression 
is related to DNA methylation of the regions studied. 
 
 7 
Sammendrag 
Lungekreft er en ledende årsak til kreftdødsfall på verdensbasis. Kreft er forårsaket av 
akkumulering av genetiske og epigenetiske endringer. Dette vil føre til forandringer i 
genaktivitet og fenotype. Det kommer stadig nye bevis på at epigenetiske mekanismer er 
viktige for initiering og utvikling av kreft. Tobakk inneholder mange kreftfremkallende 
karsinogener og tobakksrøyking er den fremste årsaken til lungekreft. En in vitro 
transformasjonsmodell har tidligere blitt utviklet på STAMI, der humane bronkieepitelceller 
(HBECs) ble utsatt for karsinogener fra tobakk (benzo[a]pyren, sigarettrøyk kondensat og N-
methylnitrosourea) i opptil 15 uker. To transformerte cellelinjer (HBEC-2KT og HBEC-
12KT) ble brukt som modeller for å undersøke molekylære endringer knyttet til 
transformasjon. Det første målet med denne oppgaven var å undersøke hvordan 
celletransformasjon påvirket cellemigrasjon. Det andre målet var å undersøke om DNA-
metylering kan forklare nedregulering av FOXA1 og FOXA2 genene i transformerte celler i 
forhold til ikke-transformerte celler. 
 
To metoder, det manuelle in vitro sårhelings-assay og en delvis automatisert metode ved bruk 
av IncuCyte ZOOM, ble brukt til å studere cellemigrasjon. Begge metodene innebærer å lage 
et sår i cellens monolag, og videre måle cellemigrering inn i såret i løpet av en definert 
tidsperiode. Det ble tatt bilder med lysmikroskop etter 0 og 12 timer for den manuelle 
metoden, og på timesbasis i 24 timer for IncuCyte ZOOM-metoden. Studier av DNA-
metylering ble utført ved bisulfitt-behandling av DNA etterfulgt av pyrosekvensering. 
 
Transformerte HBEC-12KT viste redusert migrasjon i forhold til sine kontrollceller (DMSO). 
HBEC-2KT transformerte celler viste også redusert migrasjon i forhold til sine kontrollceller 
(DMSO) når analysert ved hjelp av IncuCyte ZOOM. På motsatt side ble det observert økt 
migrasjon av transformerte HBEC-2KT når de ble analysert med in vitro sårhelingsassay. 
Tidligere genuttrykksanalyser av transformerte cellelinjer viste redusert uttrykk av E-kadherin 
(CDH1) og økt uttrykk av N-kadherin (CDH2), noe som er kjent som den såkalte ”cadherin 
switch” og er et kjennetegn ved EMT. Nedregulering av FOXA1 og FOXA2 genene 
understøtter dette, og kan trolig være et viktig trinn for EMT i utviklingen av kreft. 
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Nivået av DNA-metylering i FOXA1_pyro1 assay varierte mellom 35-90 % i både 
transformerte HBEC-2KT og deres kontrollceller (DMSO). For transformerte HBEC-12KT 
og deres kontrollceller (DMSO) var nivået av DNA-metylering over 90 %. I FOXA1_pyro2 
assay var nivået av DNA-metylering over 80 % i transformerte HBEC-2KT og deres 
kontrollceller (DMSO), og over 70 % i transformerte HBEC-12KT og deres kontrollceller 
(DMSO). Det er derfor vanskelig å trekke konklusjoner om hvorvidt metylering av FOXA1 er 
relatert til genuttrykk siden ikke-transformerte celler allerede hadde høyt nivå av DNA-
metylering i de undersøkte CpG områdene. I tillegg kan det spekuleres i om de undersøkte 
områdene ikke er involvert i stilning av genet siden kontrollcellene (DMSO) uttrykker genet 
til tross for høye nivåer av DNA metylering. 
 
Begge assayene i FOXA2 genet viste generelt lavere nivåer av DNA-metylering enn FOXA1 
genet. I FOXA2_cpg1 var nivået av DNA-metylering lavere enn 10 % i de transformerte 
cellelinjene (HBEC-2KT og HBEC-12KT), inkludert deres kontrollceller (DMSO). DNA-
metyleringsnivåer i FOXA2_TSS varierte mellom 0-50 % i transformerte HBEC-2KT og 
deres kontrollceller (DMSO). Flertallet av de transformerte HBEC-12KT cellene hadde DNA-
metyleringsnivåer mellom 20-50 % i FOXA2_TSS assay. Kontrollceller (DMSO) viste også 
samme nivå av DNA-metylering. Dermed var nedregulering av FOXA2 genet i transformerte 
celle linjer i kontrast til generelt lave nivåer av DNA metylering. Det ble ikke observert noen 
betydelige endringer i DNA-metyleringsnivåer mellom ikke-transformerte og transformerte 
cellelinjer. 
 
Det ble observert endringer i migrasjon mellom ikke-transformerte og transformerte 
cellelinjer. Det er imidlertid konkludert med at celle migrasjon og EMT ikke er direkte 
sammenkoblet i denne in vitro transformasjonsmodellen. Basert på 
bisulfitt/pyrosekvenseringsanalysene ble det ikke observert noen betydelige endringer i DNA-
metylering i de undersøkte CpG områder mellom ikke-transformerte og transformerte celler. 
Derfor kan det, basert på resultatene i denne oppgaven, ikke konkluderes med om 
nedregulering av FOXA1 og FOXA2 er på grunn av DNA-metylering i de undersøkte 
regionene. 
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1 Introduction 
1.1 Cancer 
Cancer is a major health problem for humans. According to Jemal et al. (2011), cancer is the 
leading cause of death in developed countries and the second leading cause in developing 
countries. However, there is an increasing problem of cancer in developing countries, due to 
aging and growth of the population. In addition, there is an increased adoption of cancer-
associated lifestyles in the developing countries, as for example smoking, physical inactivity 
and unhealthy diets. Worldwide, in 2008 there were about 12.7 million cancer cases and 7.6 
million cancer deaths (figure 1.1). Both estimated new cases and estimated deaths from 
cancer have increased the last years (Jemal et al., 2011; Parkin et al., 2005). 
 
 
As can be seen from figure 1.1, lung and bronchus cancer were the most commonly diagnosed 
cancer for men in 2008, and also the leading cause of cancer-related deaths worldwide. Breast 
cancer was the most commonly diagnosed cancer among women in 2008 as well as the 
leading cause of cancer deaths globally. Lung and bronchus cancer among men accounted for 
about 17 % of estimated new cases and 23 % of cancer deaths worldwide in 2008. Breast 
cancer in women accounted for about 23 % of new cases and 14 % of cancer deaths (Jemal et 
al., 2011).  
Figure 1.1: Estimated new cancer cases and deaths worldwide in 2008 (Jemal et al., 2011). 
FIGURE 2. Estimated New Cancer Cases and Deaths Worldwide for Leading Cancer Sites by Level of Economic Development, 2008. Source: GLOBOCAN
2008.
Global Cancer Statistics
72 CA: A Cancer Journal for Clinicians
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There is evidence of great variations in the risk of cancer according to geographical area. 
Most of the variations are due to risk factors in lifestyle and environment (Parkin et al., 2005). 
In 2008, the cancer incidence rates in the developing world were half the cancer incidence 
rates in the developed world, whereas the cancer mortality (number of deaths per 100 000 
persons per year) was the same. This might be due to later diagnosis and limited access to 
treatment in the developing world, which will have an adverse effect on cancer survival. 
Tobacco smoking is a major cause of cancer globally and there are also differences in the 
stage and degree of the tobacco epidemic. As for example in China, where they consume one 
in three of all the cigarettes produced in the world. This is due to both the huge population in 
the country and high prevalence of smoking among men in China (Jemal et al., 2011; 
Youlden et al., 2008).  
 
On the positive side, there has been a tremendous increase in the knowledge of the various 
molecular mechanisms and pathophysiology of human cancer during the past 20 years and so. 
These mechanisms might serve as new targets for drug development, that hopefully will be 
less toxic for the patients and have enhanced antitumor activity (Debeir et al., 2008).   
 
1.1.1 Lung cancer 
In 2008, lung cancer accounted for 13 % of total cases and 18 % of total deaths (Jemal et al., 
2011; Parkin et al., 2005). During the last years, there have been improvements in treatment 
of lung cancer but the prognosis still remains poor. The 5-year survival rate is only 15 % 
(Deutsch et al., 2012).  
 
There are two subtypes of lung cancer: small cell lung cancer (SCLC), which accounts for 
about 25 % of all lung cancers in Europe, and non-small cell lung cancer (NSCLC). NSCLC 
is divided into three histological types: squamous cell carcinoma, adenocarcinoma and large 
cell carcinoma. The most common are squamous cell carcinoma and adenocarcinoma. 
Squamous cell carcinoma is characterised by intercellular bridging and keratinization, but 
these morphologic features are difficult to detect in poorly differentiated tumours. 
Adenocarcinomas are highly heterogeneous and consist of a mixture of two or three histologic 
subtypes, as for example papillary adenocarcinoma and bronchioloalveolar carcinoma. Large 
cell carcinomas are poorly differentiated tumours, and shows no differentiation pattern for 
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classification into squamous cell carcinoma, adenocarcinoma or small cell carcinoma. 
Carcinomas arise from epithelia, which are cells that line walls of cavities and channels 
(Brambilla and Lantuejoul, 2008; Youlden et al., 2008; Weinberg, 2007). Lung tumours have 
a complex pattern of random cytogenetic and molecular genetic changes, and there are 
various substances that can increase the risk of development. A better understanding of 
mechanisms leading to lung cancer will provide a new insight into how to prevent the disease 
(Deutsch et al., 2012). 
 
Some risk factors for lung cancer includes exposure to carcinogens, both occupational and 
environmental, as asbestos, arsenic, radon and polycyclic aromatic hydrocarbons (PAHs), 
indoor pollution from cooking fumes and cigarette smoke (Jemal et al., 2011; Haugen and 
Mollerup, 2008). Tobacco smoking is the major cause of lung cancer, accounting for 80 % of 
the lung cancer burden in men and 50 % in women (Jemal et al., 2011). Inhalation of tobacco 
smoke can cause genetic and epigenetic changes in the respiratory epithelium during the 
process of carcinogenesis, as tobacco smoke holds numerous carcinogens (Tang et al., 2011). 
According to IARC Monograph Volume 83 (2004) PAHs, as benzo[a]pyrene (B[a]P), and 
tobacco specific nitrosoamines, as 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), 
are considered to be major lung carcinogens (Jemal et al., 2011). Activation of proto-
oncogenes and inactivation of tumour suppressor genes are some of the genetic changes that 
occur due to carcinogens in cigarette smoke (Tang et al., 2011). Hypermethylation of 
5’methylcytosine in CpG (cytosine-phosphate-guanine) islands in tumour suppressor genes is 
an important epigenetic event in the development of cancer. Promoter hypermethylation is 
important for the inactivation of many tumour suppressor genes in for example NSCLC. This 
can lead to loss of gene transcription and is a critical event in the initiation and progression of 
cancer (Lin et al., 2007). 
 
Lung cancer death rates for men in western countries are decreasing. However, in for example 
China and Africa, the smoking epidemic was established later and the prevalence of smoking 
is therefore still increasing in the majority of the areas. Females started smoking several 
decades after men, and lung cancers have a latency period of 20-40 years, hence the lung 
cancer trends of women are lagging behind and the cancer incidences are still increasing in 
many countries (Jemal et al., 2011; Klaassen and Watkins III, 2010).  
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1.1.2 Molecular biology of cancer 
Cancer is a class of diseases that is characterised by cellular mutation, increased proliferation 
and aberrant cell growth (Klaassen and Watkins III, 2010). Cells accumulate genetic and 
epigenetic changes that can lead to changes in gene activity and alter the phenotype. Over 
time, a cell population that ignores normal controls of proliferation will become cancer 
(Ponder, 2001).  
 
Cancer is caused by mutations in the genes that control proliferation or apoptosis. The vast 
majority arise as a consequence of chemical damage to DNA, and are referred to as genetic 
modifications. After DNA replication and subsequent cell division this damage is converted 
into a heritable change in DNA. Mutations giving cancer cells the ability to evade normal 
homeostatic mechanisms are the ones that are found in successful cancer cells (Bertram, 
2001). In the later years there has been emerging evidence of epigenetic events in initiation 
and progression of cancer. Epigenetics is defined as heritable changes in the activity of gene 
expression without altering the DNA sequence itself. Key mechanisms in epigenetics are 
DNA methylation, histone modifications, nucleosome positioning and regulation by non-
coding RNA (Jones and Baylin, 2002; Kanwal and Gupta, 2010). For example, methylation 
has several consequences for development of cancer. Cancer cells can enter cell cycle, avoid 
apoptosis and promote angiogenesis by methylations of genes involved in these processes. 
Also, it may lead to defects in DNA repair and loss of cell adhesion (Sharma et al., 2010). 
These processes will be dealt with in later paragraphs. 
 
Two important types of genes that play a role in development of cancer are proto-oncogenes 
and tumour-suppressor genes, that are involved in controlling cell growth and proliferation. 
Proto-oncogenes encode proteins that have functions in regulation of cell growth, apoptosis 
and differentiation. They can be activated to oncogenes by structural alterations, which can 
lead to cancer as they can cause cells ought to die to survive. This is characterised as a gain-
of-function mutation. Loss of function of tumour suppressor genes will contribute on the road 
to cancer, due to their role in inhibiting cell division and promote apoptosis when damage to 
cells cannot be repaired (Croce, 2008; Klaassen and Watkins III, 2010; Ponder, 2001).  
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1.1.3 Carcinogenesis 
Carcinogens are exogenous agents, physical or chemical, which cause neoplasia (autonomous 
growth of tissue). They can be genotoxic, meaning that they interact directly with DNA and 
damage its structure or non-genotoxic (epigenetic), which modify gene expression without 
damaging DNA (Bertram, 2001; Klaassen and Watkins III, 2010). A series of genetic and 
epigenetic alterations that lead to uncontrolled cell growth is the foundation of carcinogenesis 
(Tost and Gut, 2007). 
 
Carcinogenesis is the creation of cancer. This process involves a series of three definable and 
reproducible stages, known as initiation, promotion and progression (figure 1.2). 
 
 
Initiation is the first stage and it is a rapid and irreversible process that results in a stable and 
heritable carcinogen-induced mutation. Chemical carcinogens will bind covalently to DNA 
and form adducts. Carcinogens are known as initiating agents. The initiated cell undergoes 
selective clonal expansion and produces a preneoplastic lesion, a stage known as promotion. 
Tumour promoters function through various mechanisms, as gene expression changes, 
increasing proliferation and inhibiting apoptosis. This stage is reversed when tumour 
promoters are removed. A benign preneoplastic lesion is converted into neoplastic cancer 
during the non-reversible process of progression. Additional genotoxic events occur as the 
result of increased DNA synthesis and proliferation in the preneoplastic lesion. Autonomous 
growth, accumulation of chromosomal aberrations and karyotypic instability are hallmarks of 
progression (Klaassen and Watkins III, 2010).  
 
Figure 1.2: The process of carcinogenesis. Modified from Klaassen and Watkins III (2010). 
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1.1.4 Hallmarks of cancer 
The hallmarks of cancer are six biological capabilities cells acquire during the multistep 
development of human cancer and this contributes to complexities of neoplastic diseases. 
They include sustaining proliferative signal, evading growth suppressors, enabling replicative 
immortality, resisting cell death, induce angiogenesis and activate invasion and metastasis 
(figure 1.3). These hallmarks provide a solid foundation for understanding the biology of 
cancer (Hanahan and Weinberg, 2011). 
 
 
Cancer is a disease that involves dynamic changes in the genome. The basis is, as mentioned 
earlier, in mutations that result in activated oncogenes and the loss of function of tumour 
suppressor genes. Oncogenic mutations in the ras gene disrupt the Ras GTPase activity, 
which usually functions as a negative-feedback circuit to control cell proliferation. The 
tumour suppressor protein 53 (p53) is central in regulatory circuits for control of proliferation 
and promoting senescence and apoptosis. The p53 protein arrests cells with damaged DNA in 
the G1 phase of the cell cycle. Cancer cells circumvent apoptosis by the loss of p53, which is 
seen in more than 50 % of human cancers (Hanahan and Weinberg, 2000; Hanahan and 
Weinberg, 2011; Klaassen and Watkins III, 2010).  
 
• Production	  of	  growth	  factor	  ligands	  • Elevating	  levels	  of	  receptor	  proteins	  at	  the	  surface	  of	  cancer	  cells	  Sustaining	  proliferative	  signals	  
• Circumvent	  programs	  that	  negatively	  affect	  cell	  proliferation	  via	  tumour	  suppressor	  genes	  Evading	  growth	  suppressors	  
• Telomerase	  activity	  enhance	  resistance	  to	  senescence	  and	  apoptosis	  Enabling	  replicative	  immortality	  
• Limit	  or	  circumvent	  apoptosis	  Resisting	  cell	  death	  
• "Angiogenic	  switch"	  is	  activated	  during	  tumour	  progression	  and	  remains	  on	  Inducing	  angiogenesis	  
• Loss	  of	  E-­‐cadherin	  • Gain	  of	  N-­‐cadherin	  Activate	  invasion	  and	  metastasis	  
Figure 1.3: The six hallmarks of cancer (Hanahan and Weinberg, 2011). 
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In order to generate macroscopic tumours cancer cells must obtain unlimited replicative 
potential. Telomeres are essential for protection of the ends of chromosomes. Telomerase is a 
specialised DNA polymerase, and its presence is correlated with resistance to both senescence 
and apoptosis (Hanahan and Weinberg, 2011).  
 
Invasion and metastasis are important for the malignancy of cancers. Metastases are the cause 
of 90 % of human cancer deaths. One of the alterations during the process is the loss of E-
cadherin (epithelial cadherin), a cell-to-cell adhesion molecule (Hanahan and Weinberg, 
2000; Hanahan and Weinberg, 2011). This will be described in detail in section 1.3. 
 
By acquisition of hallmark capabilities cancer cells can survive, proliferate and initiate 
metastasis. Various mechanisms contribute and they differ according to type of tumour and 
time during the process of carcinogenesis. Enabling characteristics associated with acquisition 
of hallmark capabilities are genomic instability and tumour-promoting inflammation. 
Genomic instability will lead to generation of random mutations, as chromosomal 
rearrangements, and the inflammatory state of premalignant and malignant lesions can serve 
to promote tumour progression. This shows the dual roles of the immune system in fighting 
diseases and promoting tumour formation. Inflammation by immune cells is designed to heal 
wounds and fight infections, but it can instead lead to its inadvertent support of hallmark 
capabilities. The process of inflammation will lead to an increased inflow of growth factors, 
survival factors, extracellular matrix-modifying enzymes and inductive signals for epithelial-
to-mesenchymal transition (EMT) (Hanahan and Weinberg, 2011). 
 
Evading destruction from immune cells and reprogramming energy metabolism are emerging 
hallmarks of cancer. The immune system can also act as a barrier to tumour formation and 
progression, and by evading the system cancer cells will not be eliminated. Cancer cells have 
a metabolic switch where they limit their energy production mostly to glycolysis, known as 
the “Warburg-effect”. This metabolic phenotype is characteristic for rapidly dividing cells. 
Hence, it must provide advantages during cell proliferation. A significant increase in uptake 
and utilization of glucose is documented in human tumours (Hanahan and Weinberg, 2011; 
Lunt and Heiden, 2011). 
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1.2 Chemicals in cigarette smoke 
Upon inhalation, chemicals in cigarette smoke are deposited in airways and lungs. Genotoxic 
carcinogens in cigarette smoke may have mutagenic effects on lung cells. Cigarette smoke is 
a complex mixture of chemicals, and how it causes lung cancer is depicted in figure 1.4 
(Hecht, 2012a; Pleasance et al., 2009). 
 
Cigarette smoke contains more than 5000 constituents, and only a few of them have been 
studied thoroughly considering toxic effects. International Agency for Research on Cancer 
(IARC) have evaluated more than 70 compounds for carcinogenicity and placed them in 
group 1 (carcinogenic to humans), 2A (probably carcinogenic to humans) or 2B (possibly 
carcinogenic to humans). Some of them are listed in table 1.1 (Hecht, 2012b). 
Figure 1.4: How cigarette smoking can cause the development of lung cancer. Modified from 
Hecht (2012a). 
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Table 1.1: Major groups of carcinogens in cigarette smoke classified by IARC, and some specific 
examples of chemicals within each group. IARC classify the carcinogens into groups: group 1 
(carcinogenic to humans), 2A (probably carcinogenic to humans) and 2B (possibly carcinogenic to 
humans). ND=not detected (Hecht, 2012b). 
Chemical group Specific examples IARC 
group 
Amount in 
mainstream cigarette 
smoke, per cigarette 
Polycyclic aromatic 
hydrocarbons (PAH) 
Benzo[a]pyrene (B[a]P) 1 1-15.2 ng 
Other hydrocarbons Naphthalene 2B 65-868 ng 
N-Nitrosoamines N’-nitrosonornicotine (NNN) 
4-(methylnitrosoamino)-1-(3-
pyridyl)-1-butanone (NNK) 
1 
1 
5-270 ng 
13-223 ng 
Aromatic amines 2-Naphtylamine 1 1.47-17.2 ng 
Aldehydes Formaldehyde 
Acetaldehyde 
1 
2B 
1.6-75.5 µg 
32-828 µg 
Phenolic compounds Caffeic acid 2B Present 
Nitrohydrocarbons Nitrobenzene 2B Present 
Miscellaneous organic 
compounds 
Acrylamide 2A 2.3 µg 
Metals and inorganic 
compounds 
Arsenic 
Cadmium 
1 
1 
ND-5.5 ng 
1.6-101 ng 
 
As for 2012, there was no regulation of harmful tobacco smoke constituents in the United 
States, but some countries have set maximum levels for certain harmful constituents, as tar, 
nicotine and carbon monoxide (CO). A proposal for lowering of toxicants in cigarette smoke, 
this regulation goes for example for acetaldehyde, formaldehyde, B[a]P and CO has been 
made (Hecht, 2012b). 
 
1.2.1 Polycyclic aromatic hydrocarbons (PAHs) 
PAHs are a group of genotoxic carcinogens present at high concentrations in tobacco smoke 
and various working environments. They are formed by incomplete combustion of organic 
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matter, and require metabolic activation to DNA-reactive intermediates as epoxides. Epoxides 
are mutagenic and carcinogenic. These substances react easily with DNA and form so-called 
adducts, with miscoding consequences during replication. DNA adducts are found at 
increased levels in the lungs of smokers, compared to non-smokers. B[a]P is classical PAH, 
and is metabolized to B[a]-7,8-diol-9,10-epoxide that is its ultimate carcinogen. It is known 
that B[a]P induces EMT-related gene expression in lung cancer cells (Hecht, 2012a; Yoshino 
et al., 2007). This will be discussed in section 1.3. 
 
1.2.2 N-methylnitrosourea (MNU) 
MNU, also known as nitrosomethylurea (NMU), is defined as a carcinogen. It is similar to 
NNK, which is a major lung carcinogen as mentioned earlier. It can induce benign and 
malignant tumours after administration by various routes. MNU has been shown to cause 
cancer in for example stomach, skin, kidney and nervous systems of animals (IARC, 1978). 
MNU is an alkylating agent, and attaches an alkyl group to DNA. It is also referred to as base-
damaging (Xu et al., 2011). By exposure to MNU, there are formed pro-mutagenic 
methylated purines in DNA. This has been proposed as a critical initiating event of 
carcinogenesis. MNU is not dependent on metabolic activation (Faustman-Watts and 
Goodman, 1984). 
 
1.2.3 Cigarette smoke condensate (CSC) 
CSC is the particulate fraction of cigarette smoke, and has tumour promoting, co-carcinogenic 
and genotoxic properties. Tumour promoters are found in the weakly acidic/neutral fraction of 
the condensate. CSC is commercially produced and is often used in in vitro carcinogenesis 
studies (DeMarini, 2004; Hecht, 2012a; Hellermann et al., 2002).  
 
Studies show that CSC induces a squamous morphology and growth inhibition in human 
bronchial epithelial cells, and that the effect is mostly pronounced when using the neutral 
fraction of CSC. Squamous cells are more flattened, hence adhered to the underlying matrix 
and they become less able to migrate. This effect was seen after longer exposures to CSC. 
Bronchial epithelium has three properties by which they undergo repair; attachment to matrix, 
migration and proliferation, and exposure to CSC will likely inhibit the ability to participate 
in the repairing process (Cantral et al., 1995). 
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Luppi et al. (2005) observed a dose-dependent increase in cell proliferation by exposure to 
low concentrations (0.25-1 AU/ml) of CSC for 24 hours by studying a human pulmonary 
muco-epidermoid carcinoma cell line. Concentration was expressed as arbitrary units (AU) 
per ml, and ten AU/ml corresponded to a mean of 5 % (vol/vol) CSC. Higher concentrations 
of CSC decreased cell proliferation. High concentrations of CSC can induce cell death 
because of the high concentrations of oxidants and other radicals produced during smoking 
and inflammation. CSC upregulates expression of genes encoding proinflammatory 
molecules. For example, CSC induces activation of NFκB (nuclear factor kappa-light-chain-
enhancer of activated B cells), which is a protein complex that has a role in regulation of 
proinflammatory responses (Hellermann et al., 2002; Luppi et al., 2005).  
 
Cell proliferation plays a role in epithelial wound closure in addition to cell migration, and 
CSC can also affect this. At higher concentrations (5 AU/ml) wound closure was totally 
inhibited in the above carcinoma cell line. However, at lower concentrations (1 AU/ml) a 
significant increase in wound closure was seen. By studying primary bronchial epithelial cells 
Luppi et al. obtained similarly results regarding wound closure. Conversely, it appears that 
cell proliferation does not contribute to wound closure in primary bronchial epithelial cells, in 
the same way as migration, due to that very few proliferating cells were present in the wound 
area. It has also been described that epithelial migration is inhibited by CSC (Luppi et al., 
2005). 
 
Finally, CSC is also known to decrease E-cadherin expression and promoter activity, and 
increase mesenchymal markers as N-cadherin, fibronectin and vimentin in both human lung 
adenocarcinoma and human bronchial epithelial lung. Hence, CSC appears to be contributing 
to EMT (Nagathihalli et al., 2012).  
 
1.3 Epithelial-to-mesenchymal transition (EMT) 
Epithelial layers are multicellular structures composed of closely associated and largely 
immobile cells. The structures are stabilized by E-cadherin, which will be discussed further 
down. By undergoing so-called epithelial-to-mesenchymal transition (EMT), epithelial cells 
acquire a mesenchymal phenotype that is characterised by loosely associated cells, which 
have the ability to move (Guarino et al., 2007).  
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EMT is a fundamental event in morphogenesis, due to its involvement in generation of tissues 
and organs during embryogenesis in both vertebrates and invertebrates. Essential features are 
disruption of intercellular contacts and enhancement of cell motility (figure 1.5). During this 
process, cells move around and switch between epithelial and mesenchymal states as a part of 
organ development. In adulthood, EMT is important during wound healing. In addition, EMT 
is also closely related to cancer progression, and it is observed in numerous types of epithelial 
cancer, as for example NSCLC (Byers et al., 2013). Transformed epithelial cells often acquire 
the abilities to invade other tissues, resist apoptosis and spread by acquiring the mesenchymal 
phenotype that is suitable for migration. This leads to reversible reprogramming of the cell, 
which is transcriptionally regulated. EMT-inducing transcription factors (EMT-TFs) are 
involved in migration and invasion, and also suppression of senescence and apoptosis and 
resistance to for example chemotherapy (Byers et al., 2013; De Craene and Berx, 2013; 
Guarino et al., 2007; Hanahan and Weinberg, 2011).  
 
 
Cells possessing invasive or metastatic properties have altered levels of proteins involved in 
tethering of cells to surrounding tissue, such as cell adhesion molecules (CAMs) and 
integrins. Members of immunoglobulin and calcium-dependent cadherin families are 
examples of the former, and the ladder includes proteins that link cells to the extracellular 
matrix (Hanahan and Weinberg, 2000; Hanahan and Weinberg, 2011). Cadherins belongs to a 
superfamily of proteins that functions in cell recognition, tissue morphogenesis and tumour 
Figure 1.5: Epithelial-to-mesenchymal transition 
(EMT) involves change from stationary to 
migratory phenotype. Modified from Guarino et al. 
(2007). 
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progression. E-cadherin is the prototypical cadherin, other classical cadherins include type I 
P-, N- and R-cadherins and type II cadherins (cadherins 5-12) (Hazan et al., 2004). 
 
E-cadherin is encoded by the CDH1 (cadherin-1) gene, which is defined as a tumour 
suppressor gene. Methylation of the CDH1 promoter is a part of EMT. E-cadherin forms 
adherens junctions between adjacent epithelial cells and mediates intercellular interactions 
and is thought to regulate gap junctions. The molecule is thought to be a premise for gap 
junctional intercellular communication (GJIC), which is important for cell growth, 
differentiation of tissues and homeostasis. Studies show that GJIC was inhibited by tumour 
promoting agents and alterations in GJIC may be involved in carcinogenesis. GJIC is 
dependent on cell-cell adhesion, and E-cadherin maintains intercellular adherence junctions in 
epithelial cells. Loss of E-cadherin expression is associated with a decrease in intercellular 
adhesion. Hence, E-cadherin helps assemble cells and maintain quiescence, and increased 
expression is therefore associated as an antagonist of cell invasion and metastasis (De Craene 
and Berx, 2013; Hanahan and Weinberg, 2011; Jinn et al., 1998). Alterations in E-cadherin 
are the most widely observed modifications in cell-to-environment interactions in cancer. E-
cadherin function is lost in a majority of epithelial cancers. This can be due to mutational 
inactivation, repression of transcription by promoter DNA hypermethylation or proteolysis of 
the extracellular cadherin domain (Hanahan and Weinberg, 2000). Smokers also have low E-
cadherin levels (Nagathihalli et al., 2012). 
 
The neural cadherin (N-cadherin), encoded by the CDH2 (cadherin-2) gene, is found 
primarily in neural tissue and fibroblasts. A less stable and more dynamic adhesion of cells 
characterises the linkages mediated by N-cadherin. N-cadherin undergoes a switch in 
expression and it is upregulated in invasive tumour cell lines. The protein is a potent inducer 
of invasion and metastasis, and cells expressing N-cadherin show a more efficient migration. 
Changes in cadherin expression can be referred to as the “cadherin switch”, and is a crucial 
event in tumour progression. By switching from E-cadherin to N-cadherin a signalling 
program is activated that promotes invasive, motility and survival capacities of tumour cells. 
Collaboration between tumour cells and the microenvironment is also important for tumour 
progression, and the cadherin switch encourages this. In breast tumour cells it has been 
observed that N-cadherin facilitates adhesion of cells to endothelial monolayers in blood 
vessels (Gravdal et al., 2007; Hazan et al., 2000; Hazan et al., 2004). 
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1.3.1 Forkhead-box (FOX) family proteins 
FOX proteins are a family of transcription factors involved in regulation of cell growth, 
differentiation, embryogenesis and longevity. The FOX proteins bind DNA and are involved 
in transcriptional regulation and DNA repair. Mutations of FOX proteins are often associated 
with human diseases, due to its involvement in a variety of processes. They are involved in 
carcinogenesis as oncogenes or tumour suppressor genes. FOXA1 and FOXA2 proteins are 
expressed in lungs. Studies have shown that FOXA1 gene may be amplified in lung cancer, 
and in some cases of lung cancer this might lead to overexpression of the gene. This may 
indicate an oncogenic role of this gene in carcinogenesis. FOXA1 binds within highly 
condensed chromatin regions, mainly in enhancer regions, and activates FOXA1-dependent 
enhancers, which is accompanied by demethylation of DNA (Katoh et al., 2013; Lin et al., 
2002; Sérandour et al., 2011; Song et al., 2010; Wan et al., 2005).  
 
A study indicates that FOXA2 has a positive correlation with epithelial phenotype and a 
negative correlation with mesenchymal phenotype, due to the fact that FOXA2 protein levels 
correlated with epithelial cell markers (Tang et al., 2011). Transforming-growth factor β 
(TGF-β) has been shown to induce EMT via autocrine or paracrine mechanisms and is one of 
the most important regulators of EMT. It also increases lung cancer cells ability for migration. 
Studies indicate that FOXA2 is a key target for TGF-β in regulation of EMT in human lung 
cancer cells. By overexpressing FOXA2, TGF-β-induced EMT was suppressed. FOXA2 
might have a role as a tumour suppressor by repressing slug transcription through a conserved 
binding site in the slug promoter (figure 1.6). Slug is a transcription factor and a negative 
regulator of E-cadherin expression. Also, there is evidence of hypermethylation of FOXA2 
promoter in NSCLC and epigenetic mechanisms are likely to cause the loss of FOXA2 
expression in lung cancer (Basseres et al., 2012; Tang et al., 2011).  
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Studies have indicated that the downregulation of FOXA1 and FOXA2 genes is an essential 
step of EMT in progression of pancreatic cancer (Song et al., 2010). 
 
1.4 Cell migration 
Cell migration is an important mechanism for both unicellular and multicellular organisms 
(Glaß et al., 2012, Liang et al., 2007). Wound healing, immune responses and tissue 
formation during development all depend on movement of cells. During wound healing cells 
as neutrophils, macrophages and fibroblasts move to wound site and kill microorganisms and 
remodel damaged tissue (Ananthakrishnan and Ehrlicher, 2007; Glaß et al., 2012; Liang et al., 
2007). Cell migration is a multistep process involved in cancer progression, arthritis and 
atherosclerosis (Ridley et al., 2003). Tumour cells have retained the same basic migration 
machinery for cell migration as normal, non-neoplastic cells. This includes integrins, matrix-
degrading enzymes, CAM and cell-cell communication (Friedl and Wolf, 2003). 
 
Mesenchymal cells have the ability to migrate, and they do so in a process of multiple steps, 
involving cell polarisation, protrusion extension, cell elongation and contraction. It is a 
continuous cycle of interdependent steps, which allows the cells to translocate. First, the cell 
is polarised and a pseudopod (temporarily, cylindrical finger-like protrusion) is formed at the 
leading edge of the cell, which becomes attached to the extracellular matrix for stabilisation. 
Integrins support the adhesion to the extracellular matrix. This is followed by contraction of 
Figure 1.6: FOXA2 suppresses slug transcription, which again lead to EMT suppression. 
By treating A549 cells with TGF-β the FOXA2 protein was degraded, slug was actively 
transcribed and EMT was induced. Modified from Tang et al. (2011). 
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regions of the leading edge or the whole cell body. A traction force is generated that leads to 
forward gliding of the cell body (figure 1.7). Disassembly of adhesion is observed at the 
leading edge where it accompanies the formation of new protrusions, but also at the rear 
where it promotes the retraction of the cell. 
 
The cell protrusions vary in morphology and dynamics, but they all contain actin and a 
various set of structural and signalling proteins. Dynamic rearrangements of the actin 
cytoskeleton form protrusive structures and generate intracellular forces needed for cell 
translocation. Myosin motors pull the cell forward by a continuous repeated process of 
binding, power stroke and unbinding of actin filaments. This leads to generation of a 
contractile force known as acto-myosin contractile force and completion of the migration 
cycle (Ananthakrishnan and Ehrlicher, 2007; Debeir et al., 2008; Friedl and Wolf, 2003; 
Ridley et al., 2003; Yamaguchi et al., 2005). Migration can be either random or directed by 
external influences, as chemicals in the environment (Glaß et al., 2012). 
Figure 1.7: Schematic presentation of the process 
of cell migration. Modified from Ananthakrishnan 
and Ehrlicher (2007). 
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Cancer kills patients mainly because of migratory properties of its cells. This is the process of 
metastasis, where cell migration is an important underlying mechanism (Debeir et al., 2008; 
Glaß et al., 2012; Yamaguchi et al., 2005). It is valuable to understand the essential 
mechanisms as it will accelerate the process towards effective therapeutic approaches for 
treatment (Ridley et al., 2003). Migration and invasion into tissues and intravasation into 
blood and lymphatic vessels are necessary for metastasis of cancer cells. These cells acquire a 
phenotype associated with increased expression of several genes involved in cell motility, as 
vimentin and epidermal growth factor receptor (Wang et al., 2005; Yamaguchi et al., 2005).  
 
1.5 Epigenetic mechanisms 
Epigenetic changes are heritable, reversible changes in expression of genes without leading to 
alterations in the DNA sequence itself. Processes involved in epigenetic modifications are 
DNA methylation, histone modification, nucleosome remodelling, and gene regulation by 
micro-RNAs (miRNAs). These modifications regulate accessibility and compactness of 
chromatin, which is the organisation of genetic information in the form of DNA within a cell. 
This again will influence activation or silencing of genes, which will create an “epigenetic 
landscape” that regulates how the mammalian genome reveals itself in different cell types, 
developmental stages and diseases. Epigenetic patterns serves as a guardian of cellular 
identity and determines for example cell fate and gene activity (Esteller, 2007; Kanwal and 
Gupta, 2010; Sharma et al., 2010).  
 
DNA methylation is a post-replication modification, which is almost exclusively found on 
cytosines in the dinucleotide sequence CpG. In the genome there are CpG islands, which are 
regions rich in CpG dinucleotides preferentially located at the 5’end of genes. These regions 
span the 5’ end region (promoter/enhancer, untranslated region and exon 1) of many genes. 
Approximately 10 % of the CpG dinucleotide methylation sites in the human genome are 
within gene promoters, where interaction with other chromatin factors facilitates gene 
silencing when cytosine is methylated. In normal cells, the 5’ end region is often 
unmethylated. The modification is carried out by DNA methyltransferases (DNMTs). There 
are three main DNMTs: DNMT1, DNMT3a and DNMT3b. DNMT1 is the major maintenance 
enzyme and sustains existing methylation patterns. The enzyme does so by adding methyl 
groups to hemi-methylated CpG sites in DNA after replication. DNMT3a and DNMT3b are 
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de novo methyltransferases, and they target unmethylated CpG sites for initiation of 
methylation. They are highly expressed during embryogenesis, and minimally expressed in 
adult tissues. Methylation of cytosines is an essential mechanism during mammalian 
embryogenesis and development. Genome-wide de novo methylation is known to play a 
major role in establishing embryonic methylation pattern during early development. Studies 
show that early embryonic lethality occurs if DNMT3a and DNMT3b are inactivated. During 
tissue differentiation, de novo methylation also plays an important role in organising or 
compartmentalizing the genome to establish tissue-specific gene expression patterns (Aran et 
al., 2011; Kanwal and Gupta, 2010; Okano et al., 1999; Sharma et al., 2010; Tost and Gut, 
2007).  
 
CpG island methylation is also associated with X-chromosome inactivation during 
development, which is a mechanism to achieve dosage compensation of X-linked genes. Due 
to the fact that females have two X chromosomes compared to males that only have one X 
chromosome, this needs to be equalized. Methylation of the inactive X functions as a 
maintenance mechanism for X inactivation, where the promoter becomes methylated during 
development and leads to long-term transcriptional silencing (Avner and Heard, 2001; Okano 
et al., 1999; Sharma et al., 2010). 
 
Histones comprise the nucleosome core, and they can undergo post-transcriptional 
modifications as methylation, acetylation and phosphorylation that may change the 
accessibility of chromatin or recruit other effector proteins. This can lead to either repression 
or activation of gene activity. Histone deacetylation may mediate downregulation of E-
cadherin in NSCLC. Nucleosome remodelling may also regulate gene activity through 
changes in the chromatin structure, by altering accessibility of regulatory DNA sequences to 
transcription factors. Non-coding miRNAs also regulate gene activity, through 
posttranscriptional silencing. miRNAs consists of approximately 22 nucleotides. They base 
pair with 3’untranslated regions (UTR) of target messenger RNA (mRNA) and induce its 
degradation or inhibition of translation (Nagathihalli et al., 2012; Sharma et al., 2010). Any 
miRNA can bind to a broad spectrum of different mRNAs, as there are multiple conserved 
sites for a given miRNA in the same UTR of a gene. Hence, the miRNAs possess enormous 
and complex regulatory potential. In addition, the base pairing between mRNA and miRNA is 
localised to the 5’-proximal half of the miRNA (Ambros, 2004). 
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Changes in epigenetic modifications are common in many human diseases. Aberrant 
methylation of the promoter may lead to altered gene expression and this has been associated 
with cancer (Colella et al., 2003). Hypermethylation of tumour suppressor genes may lead to 
gene silencing and is a key feature of the pathogenesis of cancer. Oncogenes may be activated 
through hypomethylation, and this process may also increase genetic instability (Esteller, 
2007; Sharma et al., 2010).  
 
Epigenetic changes occur early during carcinogenesis and often underlie malignancy (Tost 
and Gut, 2007). In humans, methylation of cytosines within CpG dinucleotides is the most 
widely studied epigenetic modification, and it is considered to be a common hallmark of all 
types of human cancer (Esteller, 2007; van Eijk et al., 2012).  
 
Cigarette smoke may trigger methylation of CpG islands in promoters and cause inhibition of 
gene expression, which has been demonstrated for many genes, highlighting the fact that 
environmental factors may alter cellular phenotypes through induction of epigenetic 
modifications (Tekpli et al., 2012; Word et al., 2013; Xu et al., 2007). The predominant model 
states that increased DNA methylation cause a decrease in gene expression, particularly in 
CpG islands and promoter regions. Nevertheless, recent studies indicate that relationship 
between genetic variation, DNA methylation and gene expression is much more complex. 
Positive correlations between DNA methylation in the gene body (transcribed portion of 
genes) and gene expression have been identified in Arabidopsis thaliana and in a variety of 
human cell lines. Gene bodies have been shown to be hypermethylated compared with other 
fractions of the genome and it is suggested that gene-body methylation may play yet unknown 
functions in multicellular organisms. Functions as for example protecting the gene body 
through methylation, regulate transcription elongation rates or control alternative promoter 
usage are suggested to depend on gene-body methylation (Aran et al., 2011; Jjingo et al., 
2012; van Eijk et al., 2012).  
 
1.6 Immortal human bronchial epithelial cell lines (HBECs) 
Normal bronchial epithelial cells have a finite replicative potential. Transfecting specific 
genes into them has generated immortal HBECs that are valuable tools in studies of lung 
pathogenesis. In this thesis, HBECs that have been immortalized by insertion of cyclin-
dependent kinase 4 (Cdk-4) and human telomerase reverse transcriptase (hTERT) were used 
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(Ramirez et al., 2004). Cdks are heterodimeric complexes composed of both catalytic (kinase) 
and regulatory (cyclin) subunits. They are divided into two groups depending on their roles in 
cell cycle progression or regulation of transcription. Cdk-4 is a member of the first group and 
is a core component of the cell cycle machinery. It phosphorylates retinoblastoma protein 
(Rb) and further facilitates G1 to S (synthesis) transition in the cell cycle. In a 
hypophosphorylated state, Rb prevents cells to progress into S phase. Cyclin-dependent 
kinase inhibitor 2A (p16) is also a regulator of G1 progression, and belongs to INK4 family of 
cell cycle inhibitors. They act as inhibitors of Cdk-4 and 6. As cells age, p16 accumulates and 
associates with Cdk-4 and 6 to induce release of D-type cyclins, and then further arrest cells 
in G1. By overexpression of Cdk-4, this arrest is prevented and cells continue in the cell cycle 
(Ramirez et al., 2004; Shapiro, 2006). 
 
Telomerase is an enzyme that adds DNA sequence repetitions at the ends of chromosomes; 
the telomeres, and by this prevents progressive shortening of the ends. The telomerase 
hypothesis suggests that this is the mitotic clock, which regulates senescence in somatic cells. 
By expression of hTERT, telomere-dependent senescence can be bypassed and in 
combination with overexpression of Cdk-4 continuously replicating, immortal cell lines is 
generated (Ramirez et al., 2004). 
 
1.6.1 In vitro transformation model of HBECs 
An in vitro premalignant transformation model had been established in our lab, where HBECs 
(table 1.2) were exposed to tobacco smoke carcinogens (B[a]P, CSC or MNU) for up to 15 
weeks. Control cells were HBECs exposed to DMSO (table 1.3). The various doses of 
carcinogens were decided by toxicity tests of the cell lines, where the chosen doses should be 
as high as possible without causing too much toxicity (80 % or more of the cells should 
survive the dose given). 
 
Table 1.2: Characteristics of the donor patients of the HBECs used in this thesis. NSCLC denotes 
non-small cell lung cancer 
Cell line Age Gender Diagnosis Smoking history 
HBEC-2KT 68 M NSCLC Smoker 
HBEC-3KT 65 F No cancer Smoker 
HBEC-12KT 55 F NSCLC Previous smoker 
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Table 1.3: HBECs used in this thesis and the treatment they received. 
Cell lines Treatment 
HBEC-2KT control cells HBEC-2KT cells exposed to DMSO 
HBEC-2KT-CSC.L HBEC-2KT cells exposed to a low dose of CSC (1 µg/ml) 
HBEC-2KT-CSC.H HBEC-2KT cells exposed to a high dose of CSC (3 µg/ml) 
HBEC-12KT control cells HBEC-12KT cells exposed to DMSO 
HBEC-12KT-CSC.L-A HBEC-12KT cells exposed to a low dose of CSC (1 µg/ml), 
isolated from colony A 
HBEC-12KT-CSC.L-B HBEC-12KT cells exposed to a low dose of CSC (1 µg/ml), 
isolated from colony B 
HBEC-12KT-CSC.H HBEC-12KT cells exposed to a high dose of CSC (3 µg/ml) 
HBEC-12KT-B[a]P.L HBEC-12KT cells exposed to a low dose of B[a]P (0.33 µM) 
HBEC-12KT-B[a]P.H HBEC-12KT cells exposed to a high dose of B[a]P (1 µM) 
HBEC-12KT-MNU HBEC-12KT cells exposed to MNU (0.5 µM) 
 
During the transformation assay, cells were exposed to the treatments weekly; a control 
(DMSO) was also included. After 9, 12 and 15 weeks colony formation in soft agar was tested 
for the cell lines exposed to carcinogens. Transformation of cells leads to changes in 
phenotype, as for example anchorage independency. This capacity gives the cells abilities to 
form colonies in soft agar and these cells were defined as transformed. For the establishment 
of transformed cell lines, colonies from soft agar after 12 weeks exposure were chosen. One 
colony was chosen for all the cell lines, except for HBEC-12KT-CSC.L where two colonies 
were isolated (A and B). The colonies were isolated and seeded in soft agar a second time to 
ensure persistency of anchorage independent growth. Colonies were also formed after second 
time in soft agar. Four colonies were isolated from each treatment (2A, 2B, 2C and 2D) and 
seeded in single dishes to obtain clonal transformed cell lines (all cells originated from the 
same colony) (Sjøberg, 2012). The transformation model is depicted in figure 1.8, and the 
naming of the cells lines are explained in figure 1.9. 
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When transformed, these cell lines were suitable models for further investigations of 
molecular changes involved in the process of transformation. Earlier studies indicate that 
transformation is associated with changes in cellular morphology, from an epithelial to a 
mesenchymal-like shape, and also changes in migration capability of the cells, which indicate 
activation of EMT (Sjøberg, 2012). Gene expression analyses (figure 1.10) showed reduced 
Figure 1.8: Colony formation of transformed HBEC-2KT and HBEC-12KT in 
soft agar after 9, 12 and 15 weeks. After 12 weeks, colonies were isolated and 
seeded into soft agar a second time to ensure anchorage independent growth. 
From second time in soft agar, four colonies from each treatment were isolated. 
Figure 1.9: Naming of the cell lines used during this thesis. 
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expression of FOXA1, FOXA2 and CDH1 (E-cadherin) genes in HBEC-2KT and HBEC-
12KT transformed cells compared to control cells (DMSO). CDH2 (N-cadherin) gene had 
increased expression in all of the transformed cell lines of HBEC-2KT and HBEC-12KT 
compared to control cells (DMSO). These changes in the transformed cell lines are consistent 
with EMT. Audun Bersaas (staff engineer at STAMI) performed the gene expression 
analyses. 
 
 
1.7 Aim of the study 
The aim of this study was to investigate mechanisms involved in development of lung cancer. 
There was a special focus on epigenetic changes, which have proved to be important during 
the later years considering initiation and progression of cancer. HBECs were exposed to 
B[a]P, CSC and MNU in an already developed in vitro transformation model.  
 
The first aim was to investigate how transformation affected cell migration, and relate this to 
previous gene expression analyses in EMT-related genes as CDH1 and CDH2, and also 
FOXA1 and FOXA2 in transformed compared to non-transformed cells. 
 
The second aim was to investigate whether downregulation of FOXA1 and FOXA2 gene 
expression in transformed versus non-transformed cell lines could be explained by DNA 
methylation. 
Figure 1.10: Fold change of gene expression of FOXA1, FOXA2, CDH1 (E-cadherin) and 
CDH2 (N-cadherin) genes in in vitro transformed HBEC-2KT and HBEC-12KT. Numbers (log-
scale) denotes how much gene expression has decreased/increased compared to control cells 
(DMSO). 
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2 Materials and methods 
Various methods used during this thesis to study characteristics of transformed and non-
transformed HBECs are presented in figure 2.1 below. The transformed cell lines used have 
been exposed to B[a]P, CSC and MNU for 12 weeks. Control cells have been exposed to 
DMSO for 7 weeks. Untreated HBECs have been included in the cell migration analyses. 
 
 
2.1 General cell work 
All cell work was performed with ventilation in OAS LAF benches under sterile conditions, 
with the use of Bunsen burners and plastic pipettes. Information regarding the materials used 
during this thesis can be found in appendix A. General cell culture work as thawing of cells, 
passaging cells and freezing of cells is described in appendix B. The cells were grown on 
collagen-coated dishes, either 96- and 6-well plates or 100 mm plates. Information regarding 
collagen coating is also described in appendix B. When the cells had reached about 80 % 
confluence they were passaged.  
 
2.1.1 Cell lines and cell culture 
Cells were taken from the liquid nitrogen cell bank at STAMI and cultured in an incubator (37 
°C, 5% CO2 atmosphere) until further experiments. It was always used the lowest possible 
passage number of the cells. Untreated HBEC cell lines were grown in LHC-9 medium, 
supplemented with penicillin and streptomycin (1 %). Transformed HBEC cell lines and 
control cells (DMSO) were grown in LHC-9 medium, supplemented with penicillin and 
Figure 2.1: Overview of methods used. 
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streptomycin (1 %) and foetal bovine serum (FBS) (10 %). Fresh medium was given 
approximately twice a week. 
 
2.1.2 Seeding of cells for various experiments 
This is a general description of the procedure. Volumes of different solutions and reagents 
varied according to the experiment performed, this is an example when using 100 mm petri 
dishes.  
1. Starting material was always approximately 80 % confluent cell cultures. 
2. The media over the cells was removed, and the dishes were washed twice with 
phosphate buffered saline (PBS) (10 ml). 
3. Trypsin solution (1 ml) was added to the dishes. 
4. The cells were incubated (37 °C) until detachment from the petri dish. This was 
monitored in the light microscope. 
5. Medium (5 ml) was added and the cell suspensions were gently washed up and down a 
10 ml pipette for separation of cells and washing of petri dish. 
6. The cell suspension was transferred to a centrifuge tube and centrifuged (1000 rpm, 4 
minutes). 
7. The supernatant was discarded and the pellet was re-suspended in growth medium (5 
ml). 
8. Cell suspension (10 𝜇l) was mixed with trypan blue stain (10 𝜇l) in an eppendorf tube, 
and 10 𝜇l of this mix was added to a cell counting chamber slide. 
9. Cells were counted using Countess Automated Cell Counter. 
10. The cells were then added growth medium to obtain the appropriate density of the 
cells. 
11. Cells were seeded on appropriate plates. 
12. Plates were incubated (37 °C) for further use. 
 
2.2 Soft agar assay 
Growth in soft agar is an indication of cell transformation (anchorage independent growth). 
Tumour cell line A549 was used as a positive control in this assay. The soft agar assay is 
based on a top- and base-layer, where the base-layer (0.7 % agar) is made first. When the 
base-layer has congealed, a top-layer is added. The top-layer is made of a lower agar 
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concentration (0.35 %) where a specific number of cells are added. Two parallels were made 
for each cell line. To make the soft agar, the 3 % agar solution was kept in a water bath at 50 ℃ and when cells were added to the lower agar concentration the solutions were kept in a 
water bath at 40 ℃. It was important to work rapid and efficiently, due to the rapid 
solidification of agar solutions and in order to keep the cell at temperatures above 37 ℃ for as 
short time as possible. 
1. 1 g Difco Agar Noble was mixed with 33.3 ml PBS to obtain a stock agar solution of 3 
%. 
2. The agar solution was autoclaved on the program for liquids. 
3. Agar stock solution (3 %) was mixed with growth medium to obtain an concentration 
of 0.7 %, which formed the base-layer. 
4. 0.7 % agar solution (1.5 ml) was added to each well on 6-well plates and this was left 
to gel at 4 ℃ (30 minutes). 
5. Cells were trypsinised and counted. The cell suspension was diluted in medium to 
obtain 4x104 cells/ml. 
6. The diluted cell suspension was mixed with an equal volume of the 0.7 % agar 
solution to obtain a top-layer of 0.35 % agar. This layer would then have 2x104 
cells/ml. 
7. The top-layer (1 ml) was added over the base-layer. 
8. The plates were left to gel at 4 ℃ (30 minutes). 
9. The plates were then incubated at 37 ℃ for 3-4 weeks to evaluate appearance of 
colonies. 
10. After two days, 500 𝜇l fresh medium was added, and this was repeated once a week. 
 
2.2.1 Visualisation of colonies by crystal violet staining 
Crystal violet was used to visualise colonies in soft agar. When dissolved in water, crystal 
violet has a blue violet colour. The substance colours cell walls, and makes the cells easy to 
visualise in a light microscope. 
1. A crystal violet solution (0.05 %) was diluted 10x with autoclaved water to make a 
solution of 0.005 %. 
2. The 0.005 % crystal violet solution was added (500 𝜇l) to the soft agar plates, which 
were then incubated for 30 minutes (37 ℃). 
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3. Colonies were visualised in the light microscope and images were taken. 
 
2.3 DNA Isolation 
DNA was isolated using Wizard® Genomic DNA Purification Kit (Promega). This kit is 
designed for isolation of genomic DNA from various tissues and cells, one of them being cell 
cultures. The purification procedure includes four steps. The first step is lysis of cells and 
nuclei, followed by an RNase digestion step. The third step is salt precipitation, where cellular 
proteins are precipitated and leave high molecular weight genomic DNA in solution. The last 
step includes concentration and desalting of DNA by isopropanol precipitation (Wizard® 
Genomic DNA Purification Kit, Promega, 2010).  
1. Tissue culture cells grown on 100 mm dishes were trypsinised and counted. The cell 
suspension was diluted in medium to obtain a concentration of 3x106 cells. 
2. The solution was centrifuged at 16 000 g for 10 seconds, or 1000 rpm for 4 minutes if 
the volume was above 1.5 ml, at room temperature. 
3. The supernatant was removed and the pellet was washed with PBS (200 𝜇l) 
4. The solution was centrifuged as above. 
5. The supernatant was removed until there was 10-15 𝜇l left in the tube. 
6. Nuclei Lysis Solution (600 𝜇l) was added to lyse the cells. Lysate was transferred to 
eppendorf tubes if volume was above 1.5 ml. 
7. RNase Solution (3 𝜇l) was added to the nuclear lysate and the tube was mixed by 
inversion 2-5 times. 
8. The mixture was incubated at 37 ℃ for 30 minutes, and left at room temperature for 5 
minutes to cool down. 
9. Protein Precipitation Solution (200 𝜇l) was added to the mixture, which was then 
vortexed for 20 seconds. The sample was left on ice for 5 minutes. 
10. The tube was centrifuged at 16 000 g for 10 minutes at 4 ℃. 
11. The supernatant was transferred to an eppendorf tube with 600 𝜇l room tempered 
isopropanol. 
12. The solution was inverted until DNA formed a visible mass. 
13. The tube was centrifuged at 16 000 g for 1 minute at room temperature. 
14. The supernatant was discarded. 
15. Ethanol (70 %, room tempered) was added and the tube was inverted to wash DNA. 
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16. The tube was centrifuged at 16 000 g for 1 minute at room temperature. 
17. Ethanol was carefully removed from the tube containing DNA. 
18. The tube was inverted on a paper, and the pellet was left to dry for 10-20 minutes. 
19. DNA Rehydration Solution (50 𝜇l) was added. 
20. The tube was incubated at 65 ℃ for an hour, and the solution was gently mixed every 
15 minutes. 
DNA was stored at 4 ℃, until further applications as PCR amplification, bisulfite treatment 
and pyrosequencing. 
 
2.3.1 Quality and quantity of DNA 
NanoDrop spectrophotometer was used to assess the quality and quantity of DNA. NanoDrop 
utilizes a retention technology. A beam of light is passed through a droplet of sample and 
measures the intensity of light that is transmitted through it (NanoDrop 8000 
Spectrophotometer, V2.2 User Manual, Thermo Scientific). Absorption maximum of nucleic 
acids is 260 nm. The ratio OD260/OD280 can be calculated to assess purity of the solution. For 
DNA a ratio of 1.8 indicates that it is pure. A low ratio can be due to contamination by 
proteins or phenols. The ratio 260/230 is a secondary measure of nucleic acid purity. 260/230 
is usually in the range between 1.8 and 2.2, and if lower this can be an indication of the 
presence of co-purified contaminants (Barbas et al., 2007).  
 
2.4 Agarose gel electrophoresis 
Agarose gel electrophoresis separates DNA fragments of different size in an electric field. 
Smaller fragments migrate faster than larger ones (Reece, 2004). In this thesis, agarose gel 
electrophoresis was used to test if PCR products had the correct length and if there was only 
one product. It was also used to check quality and quantity of PCR products before carrying 
out the pyrosequencing. 
 
A DNA standard ladder was run alongside the samples during gel electrophoresis to estimate 
the size of unknown DNA samples and identify the band of interest. Different ladders were 
used, as for example 100 bp DNA ladder and ϕX174 DNA/HaeIII marker, which was used in 
this thesis. 
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1. 50X TAE buffer was diluted to 1X TAE buffer: 
a. 8 ml 50X TAE + 392 ml dH2O to make a small gel. 
b. 24 ml 50X TAE + 1176 ml dH2O to make a large gel. 
2. Agarose powder was weighed: 
a. 2.4 g SeaKem GTG Agarose in 120 ml 1xTAE buffer to make a 2 % gel for 
testing of PCR products for pyrosequencing. 
b. 1.5 g NuSieve 3-1 Agarose in 50 ml 1xTAE buffer to make a 3 % gel for 
genomic DNA testing. 
3. The mixture was heated in a microwave to make a clear solution. 
4. GelRed (7 µl for large and 2.5 µl for small gels) was added for staining of DNA. 
5. The solution was poured into a gel former containing a comb to form wells and left to 
set. 
6. The comb was removed, the gel was placed in aqueous buffer and DNA was loaded in 
the wells: 
a. PCR products for pyrosequencing: 1 µl sample. PCR products for 
pyrosequencing contained a CoralLoad Concentrate, so no loading buffer was 
necessary. 
b. Genomic DNA: 3 µl sample + 1 µl loading buffer. 
7. Large gels were run at 120 V and small gels at 100 V, both for about 1.5 hours. 
8. The gels were examined under UV-light to see the localisation of DNA bands. 
 
2.5 Cell migration assay 
Two methods were used to study cell migration. Both assays are based on observations that 
when a scratch is made in a cell monolayer, the cells at the edge of the newly formed opening 
will move towards it and close the wound (Glaß et al., 2012; Liang et al., 2007; Rodriguez et 
al., 2005). Using IncuCyte ZOOM, from Essen Biosciences, the method of studying cell 
migration was mainly automated. The other method used was the manual in vitro scratch 
assay.  
 
2.5.1 IncuCyte ZOOM 
The migration assay from Essen BioSciences can be used to assess the 2D migration potential 
of various cells. The IncuCyte ZOOM instrument was only in the house for a demo for three 
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weeks. A 96-well WoundMaker was used to create a cell-free zone in a monolayer, without 
disrupting the coating of the wells. ImageLock plates (Essen Biosciences) were used for this 
purpose. These plates had markers on the bottom of the plate that serve as a reference point 
for accurate picturing. After wounding fresh media was added to the wells and the 96-well 
plate was put in the IncuCyte ZOOM instrument to be monitored for a chosen time course. 
Usually for 24 hours. The instrument can automatically acquire images at a chosen interval 
during the experiment. When the assay was completed, images were analysed using 
IncuCyte’s integrated software, which provides ways to quantify both migration and invasion. 
The whole process is outlined in figure 2.2. 
 
 
1. 25 000 cells/well were plated on 96-Well ImageLock plates, which were left in the 
incubator to form a confluent monolayer (37 ℃, 1 day). 
2. Wounds were made using the 96-pin WoundMaker. 
3. Plates were washed twice with PBS (2*200 µl/well). 
4. Fresh media (100 µl) was added to the wells and the plate was placed in the IncuCyte 
ZOOM instrument inside the incubator. 
5. The plates were allowed to equilibrate within the instrument for minimum 15 minutes 
before the first scan. The software was set to take images every hour for 24 hours with 
“Scratch Wound” as the experimental type. 
 
Analysis of results 
For processing of the data an image collection was created using a representative number 
(three to five) of images. A Processing Definition was used to analyse the data, via a 
Figure 2.2: The process of making wounds using the Essen 96-Well WoundMaker for migration 
assay with IncuCyte ZOOM. Modified from Roddy et al. (Roddy et al., s.a.). 
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Processing Software Package in the instrument. The data from the migration assay was 
analysed using the metric Relative Wound Density (RWD), which is an algorithm that is a 
part of the IncuCyte software tool. It is robust across multiple cell lines. This algorithm 
measures cell density in the wound area relative to the cell density outside the wound area at 
every set time point. At t=0, the RWD is set to be zero. When the cell density inside the 
wound is the same as the cell density outside the initial wound the RWD is 100 % (Roddy et 
al., s.a.). Graphs were made using the software. 
 
2.5.2 In vitro scratch assay 
The manual in vitro scratch assay involved creating a scratch in the cell monolayer using a 
pipette tip, capturing images at regular intervals during the cell migration process and analysis 
of images to quantify percentage methylation. 
 
CellProfiler was used for analysis of the results. Different modules in the software process the 
cell images. The modules are placed in a sequential order to create a “pipeline”, typically 
starting with image processing, followed by object identification and at last, measurements.  
The modules are mostly automatic, but some of them are interactive, where the user can 
optimize for particular cell types and experimental conditions. The different modules can be 
mixed and matched for a specific usage and each of the modules settings can be changed 
according to the purpose (Carpenter et al., 2006).  
1. 5x105 cells/well were plated on 6-well plates, which were left to form a confluent 
monolayer (37 ℃, 3-4 days). 
2. Scratches were made in the cell monolayer with a yellow pipette tip, as shown in 
figure 2.3. The plates were marked on the bottom side according to figure 2.4 to 
ensure that the images were taken on the same place. The cells were washed once with 
PBS and fresh medium (2 ml) was added. 
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3. An initial light microscope image of each scratch wound was taken (0 hours). 
4. Plates were placed in an incubator. 
5. Another light microscope image was taken after 12 hours. 
6. The images were analysed using CellProfiler. 
 
Analysis of results 
Light microscope images of scratch wounds were analysed using CellProfiler. An example 
pipeline for wound healing at the CellProfiler web page was used as basis. By testing different 
combinations of the different algorithms we developed a pipeline suited for this study. 
Appendix C presents the development of the pipeline. Calculation of percentage migration 
was done using the formula: 
Figure 2.3: Schematic presentation of scratch 
making with a pipette tip in 6-well plates for the 
cell migration assay. 
 
Figure 2.4: How the plates were marked 
on the bottom side to ensure that images 
were taken at the same spot. Black lines 
denote the marking, yellow the 
scratching and a blue square where the 
images were taken. 
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2.6 DNA sodium bisulfite treatment 
Sodium bisulfite treatment of DNA is used to convert unmethylated cytosines to uracil 
through the process of deamination. Methylated cytosines will remain unchanged, and this 
allows cytosine to be distinguished from 5-methylcytosine. Methylation status of DNA is 
represented by a ratio of cytosine and thymine, as thymine will be incorporated in place of 
uracil during PCR (Dupont et al., 2004; Yang et al., 2004). 
1. The following solutions were prepared freshly: 
a. 6.07 g sodium metabisulfite in 12 ml dH2O 
b. 110 mg hydroquinone in 5 ml dH2O 
2. Solutions were mixed on an agitator until dissolved. 
3. A 6.3 M solution of sodium hydroxide (NaOH) was prepared freshly:  
1.26 g NaOH in 5 ml dH2O. 
4. The pH of sodium metabisulfite was adjusted to 5 by adding 750 µl NaOH. 
5. Hydroquinone (450 µl) was added to the sodium metabisulfite, and the solution was 
heated to 55 °C. 
6. DNA (1 µg in 20 µl TE-buffer) was spun down (30 sec, 3000 rpm) and the sample was 
denatured on a thermomixer at 95 °C, 400 rpm for 23 minutes. 
7. The sample was spun down at 3500 rpm for 30 seconds and added 2 µl NaOH, mixed 
and spun down (3000 rpm, 30 seconds). The sample was then incubated for 10 
minutes at 39 °C. 
8. Pre-warmed bisulfite/hydroquinone solution (416 µl) was added to the DNA sample, 
which was mixed well and spun down quickly. 
9. A cyclic reaction was run according to table 2.1: 
 
 
U0 = total area - occupied area at 0 hours 
U12 = total area - occupied area after 12 hours 
U! − U!"U! ∗ 100 
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            Table 2.1: Setup for bisulfite treatment of DNA by cycling reaction 
Temperature (°C) Time (min)  
58 15 15 
cycles 95 1  
 
10.  4 sets of eppendorf tubes were prepared: 
a. 2 sets of tubes without lids, 1.5 ml. 
b. 2 sets of tubes with lids, 1.5 ml. 
11. DNA was cleaned using Promega Wizzard DNA Clean Up Kit. The Resin bottle was 
mixed well before use, and 1 ml Resin was added to one set of eppendorf tubes with 
lids. The bisulfite treated DNA was added to each tube, which was mixed by 
inversion. 
12. The filter and 10 ml syringe were linked together and attached to the vacuum pump 
station. The DNA/Resin mix was added to each syringe, vacuum was applied and the 
liquid was allowed to pass through the filter. Then, 2 ml 80 % isopropanol was added 
to each syringe, and DNA was now desalted in the filter. The syringes were discarded. 
13. The filters were transferred to clean 1.5 ml eppendorf tubes without lids and 
centrifuged (10 000 g, 2 minutes, room temperature). 
14. Again, the filters were transferred to clean eppendorf tubes without lids. 50 µl TE-
buffer (55 °C) was added directly to the filter and incubated 1 minute at room 
temperature. 
15. Filters were centrifuged at 10 000 g for 30 seconds and 12 000 g for 30 seconds to 
elute the DNA. The filters were discarded. 
16. NaOH (2.5 µl) was added. The sample was mixed and spun down. The samples were 
incubated at 42 °C for 20 minutes at 400 rpm on a thermomixer. This was the 
desulphonation step. 
17. Ammonium acetate (NH4OAc) (22.5 µl) and acrylamide (5 µl, 0.25 %) were added to 
an eppendorf tube with lid. The DNA was added to the mixture, mixed and spun 
down. 
18. Ice-cold (-80 °C) 96 % ethanol (1 ml) was added and the tubes were inverted 4x. The 
tubes were then incubated at -20 °C for 10 minutes. 
19. The tubes were centrifuged at 20 000 g for 15 minutes at -4 °C. 
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20. The supernatant was removed and cold (-20 °C) 70 % ethanol (1 ml) was added. The 
mixture was vortexed and spun down at 20 000 g for 15 minutes at -4 °C. The 
supernatant was removed and the washing step was repeated. 
21. The DNA was left to dry after final removal of supernatant. 
22. DNA was resuspended in elution buffer (25 µl) and incubated at 60 °C for 1-2 
minutes. The tubes were cooled down on ice, spun down and stored at -20 °C for later 
use. 
 
2.7 PCR using PyroMark PCR kit 
By using a thermal cycler, segments of DNA are amplified via the principle of PCR. 
Repetitive cycles of heating and cooling will amplify the DNA sequence flanked by two 
primers. There are three steps in each PCR cycle: denaturation, annealing and extension. 
Denaturation is the use of heating to separate two DNA strands. The temperature is lowered 
and the two primers bind to the target DNA in a process named annealing. Finally, DNA 
polymerase binds to the free 3’-end of the primers and start extending the DNA sequence 
(Reece, 2004). In this thesis, PCR was used to amplify desired segments of bisulfite treated 
DNA for further analysis by pyrosequencing. It was important that one primer was 
biotinylated for further isolation of PCR products by Sepharose beads. 
 
A challenge arises when amplifying bisulfite treated DNA, due to the presence of uracil and 
DNA mainly consisting of three bases: adenine, thymine and guanine. Due to the reduced 
complexity there is an increased risk of mispriming and nonspecific product can be formed. 
Qiagen has overcome this by a unique mastermix that ensures specific primer binding, 
prevents mispriming and minimizes the production of artefacts and redundant biotinylated 
primer, which can interefere with pyrosequencing. HotStarTaq DNA polymerase requires a 
15-minute activation step, which prevents formation of primer-dimers and misprimed 
products at low temperatures. The PyroMark PCR buffer has a unique combination of salts 
that ensures a high ratio of specific-to-nonspecific primer binding. CoralLoad Concentrate 
was added to ensure specific PCR and high yields of the amplified DNA. Q-solution 
facilitates amplification of templates high in secondary structures and GC content. The 
solution modifies the melting behaviour of DNA. Magnesium stabilizes DNA and raises the 
melting temperature (PyroMark PCR Handbook, 2009, Qiagen). 
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PyroMark Assay Design 2.0 was used to design primers. The software generates primer set 
that includes both PCR and sequencing primers and each set is given a quality score based on 
several parameters specific for the Pyrosequencing procedure. For this thesis four sets of 
primers were designed, Audun Bersaas (staff engineer at STAMI) did help with this. Two 
assays for the FOXA1 gene, named FOXA1_pyro1 and FOXA1_pyro2, and two assays for the 
FOXA2 gene, named FOXA2_cpg1 and FOXA2_TSS (their positioning is depicted in section 
3.4.1). Information regarding the different primers can be seen in table 2.2. The reverse 
primers had a biotinylated 5’-end. 
 
Table 2.2: Primers used for PyroMark PCR. 
Primers Position, 5’-3’ 
Length 
(bp) 
% GC Tm (°C) 
Amplicon 
(bp) 
FOXA1_pyro1 (forward) 120-140 21 42.9 59.7  
FOXA1_pyro1 (reverse) 383-361 23 43.5 59.4 264 
FOXA1_pyro2 (forward) 1201-1228 28 39.3 61.4  
FOXA1_pyro2 (reverse) 1346-1326 21 42.9 59.1 146 
FOXA2_cpg1 (forward) 9-29 21 42.9 55.7  
FOXA2_cpg1 (reverse) 259-234 26 50.0 60.0 251 
FOXA2_TSS (forward) 1216-1245 30 23.3 56.7  
FOXA2_TSS (reverse) 1552-1525 28 32.1 58.8 337 
 
1. A mastermix was made for each primer assay. Table 2.3 shows the setup for the 
different mastermixes and table 2.4 contains information regarding the different 
optimized conditions for the PCR reaction. 
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Table 2.3: PyroMark PCR-setup for the different FOXA pyrosequencing assays 
Reagents 
 
Volume/sample 
(µl): 
FOXA1_pyro1 
 
Volume/sample 
(µl): 
FOXA2_cpg1 
Volume/sample 
(µl): 
FOXA1_pyro2, 
FOXA2_TSS 
dH2O 6 3.75 5 
PyroMark PCR Master 
Mix, 2X 
12.5 12.5 12.5 
CoralLoad 2.5 2.5 2.5 
Q-Solution 0 2 0 
MgCl2, 25 mM 0 0 1 
Primer up, 10 pmol/µl 0.5 0.75 0.5 
Primer up, 10 pmol/µl 0.5 0.5 0.5 
Template DNA 3 3 3 
Total volume 25 25 25 
 
 
Table 2.4: PyroMark PCR-setup. For FOXA1_pyro1 and  
FOXA2_cpg1 the annealing step is at 60 °C, whereas for  
FOXA1_pyro2 and FOXA2_TSS the temperature is 58.5 °C. 
Step Temperature (°C) Time  
Activation 95 15 min  
Denaturation 94 30 sec  
47 cycles 
 
Annealing 60/58.5 30 sec 
Extension 72 30 sec 
Final extension 72 10 min  
 4 ∞  
 
2. Template-DNA was added. 
3. After completion of the PCR, 1 µl of the PCR products were used for agarose gel 
electrophoresis on a 2 % gel. 
4. The products were kept at -20 °C for further use. 
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2.8 Pyrosequencing 
Pyrosequencing is a based on a real-time sequencing-by-synthesis technology, and it relies on 
detection of pyrophosphate release when a nucleotide is incorporated during synthesis 
(Langaee and Ronaghi, 2005). The released pyrophosphate is converted to adenosine-5’-
triphosphate (ATP) by sulfurylase, which is sensed by the enzyme luciferase that converts 
ATP to light. The principle is illustrated in figure 2.5. 
 
 
The pyrosequencing software generated a dispensation order according to the known DNA 
sequence, and only one of the four bases (adenine, thymine, cytosine and guanine) was added 
at a time in terms of the dispensation order. Since the DNA sequence is already known, it is 
performed a re-sequencing of the DNA to determine the ratio of cytosine and thymine in CpG 
sites. From these results the software can decide the methylation percentage in each CpG site. 
 
The intensity of the light is proportional to the number of bases incorporated. Deoxyadenosine 
alpha-thio triphosphate (dATPαS) is added instead of deoxy-ATP (dATP), as it recognized by 
DNA polymerase but not luciferase. Before another nucleotide is added the previous one is 
degraded by apyrase. The process is repeated until the DNA sequence is determined (Dupont 
et al., 2004; Langaee and Ronaghi, 2005).  
Figure 2.5: When a nucleotide is incorporated by polymerase during synthesis a pyrophosphate 
is released. This molecule is further converted to ATP by sulfurylase, and luciferase further 
produces light. This is detected as peaks in the pyrogram. A double peak indicates incorporation 
of two nucleotides. Apyrase then removes the nucleotides (England and Pettersson, 2005). 
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In this thesis, pyrosequencing was used to determine the number of methylated cytosines in 
various CpG sites in isolated DNA. A summary of the procedure for this thesis is shown in 
figure 2.6 and the sequences to be analysed are presented in table 2.5. 
Figure 2.6: During bisulfite treatment unmethylated cytosine is converted to uracil, whereas 
methylated cytosine remains unchanged. PCR incorporated thymine in the place of uracil, and 
during pyrosequencing thymine will represent unmethylated cytosine. Methylated cytosine 
will remain cytosine through the whole procedure (England and Pettersson, 2005). 
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Table 2.5: Sequences to be analysed by pyrosequencing. Y stands for C/T, where levels of 
methylation are to be determined 
Assay Sequence to analyse 
FOXA1_pyro1 YGYGGGTATT TYGGGTAGTY GTTAGYGGAG GAAGYGGTTT 
YGTTTTTTTY GGAAGTTGTT TTTGTTATAT TYGTGGGGTT 
TGTTTTYGGY GTAGTTTYGT AGTATTTGAG 
FOXA1_pyro2 TYGTAGGYGT TTTYGGGGAG TATYGTTAGG YGATATTGGA 
TTGAATTTYG TAYGTATTTT AGTTAGGGAT TTAGGTTT 
FOXA2_cpg1 YGTTTTTTGT YGGTYGTTAG GTTYGYGGGA TYGATTYGAG 
TTTTTATTTA TTTT 
FOXA2_TSS YGGAAYGGTT TYGGGAGAAG YGYGGGGYGT AYGGTTTGGT 
YGTTTYGGTT TTTYGATTTT TTAGATATYG GTYGTTAGGG 
ATTYGTAGTG GGGYGGTYGG YGTTTGGYGT AAGTAGTTTT 
TTTAGTAGYG GTYGAYGGTT GGGAGGTTGA GATTTGTTTT TG 
 
The process of pyrosequencing consists of several steps: 
a. Testing the PyroMark Q24 Vacuum Work Station. 
b. Immobilization of PCR products on Streptavidin Sepharose beads. 
c. Separation of DNA strands and isolation of DNA strand to be sequenced. 
d. Attachment of samples to the sequencing primers, information in table 2.6. 
e. Preparation of PyroMark Q24 Gold Reagents and pyrosequencing. 
 
Table 2.6: Sequencing primers for pyrosequencing 
Sequencing 
primers 
Sequence, 5’-3’ 
Length 
(bp) 
% 
GC 
Tm 
(°C) 
FOXA_pyro1 GAG GAT TGT AGG GTG  15 53.3 45.9 
FOXA1_pyro2 AGG GAA AGT TGA ATT TTT 18 27.8 44.2 
FOXA2_cpg1 GGG TTT TTA TAG TGA TAG GG 20 40.0 47.0 
FOXA2_TSS GTT TTT TTT TGT TAT AGT TTA 
GAT T 
25 16.0 42.9 
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2.8.1 Testing the PyroMark Q24 Vacuum Work Station 
1. A container on the PyroMark Q24 Work Station was added 70 ml dH2O and the 
vacuum pump was started. 
2. The filter tips were lowered in the water and after 20 seconds the water should be 
absorbed. 
3. A 24-well PCR plate was added dH2O (100 µl) in each well. The filter tips were 
lowered in the plate and left there for 10 seconds. Proper absorption of water from all 
the wells was inspected. 
4. The procedure was repeated if there was any trouble during the absorption. If 
problems persisted the filters were changed. 
 
2.8.2 Immobilization of PCR products to Streptavidin Sepharose beads 
1. The bottle of Streptavidin Sepharose beads was carefully mixed to obtain a 
homogenous solution. 
2. A mastermix was made: 
Streptavidin Sepharose High Performance  2 µl per sample 
Binding buffer     40 µl per sample 
dH2O       14 µl per sample 
       56 µl per sample 
3. Mastermix (56 µl) was added to each well on the PCR plate. 
4. PCR products were added to the mixture. Figure 2.7 summarises this. 
5. The plate was sealed with a lid and incubated for 10 minutes at 20 °C and 1500 rpm 
on a thermomixer. 
6. Sepharose beads sedimented rapidly and the absorption by vacuum filters was done 
quickly after incubation (section 2.10.3, point 6). 
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2.8.3 Separation of DNA strands and clearing of samples in the PyroMark Q24 plate 
1. A mastermix per sequencing primer was made: 
Annealing buffer   24.25 µl per sample 
Sequencing primer (10 pmol/ µl) 0.75 µl per sample 
25 µl per sample 
2. Mastermix (25 µl) was added to wells on the PyroMark Q24 plate. 
3. The plate was placed properly in the vacuum work station (depicted in figure 2.8). 
Figure 2.7: Immobilization of PCR 
products to Streptavidin Sepharose beads 
(PyroMark Q24 User Guide). 
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4. In the five containers on the PyroMark Q24 vacuum station different solutions were 
added: 
1. 70 % ethanol (70 ml). 
2. Denaturation solution (40 ml). 
3. 1x Washing Buffer (50 ml). 
4. dH2O (70 ml). 
5. dH2O (70 ml). 
5. The filter tips were washed in container 5, and 70 ml dH2O was added again 
6. The PCR plate was placed in the vacuum workstation and the filter tips were slowly 
lowered into the plate to catch the beads with immobilized template. The filter tip 
holder was left there for 15 seconds. 
7. The filters were washed in: 
a. 70 % ethanol for 7 seconds. 
b. Denaturation solution for 7 seconds. 
c. Washing buffer for 16 seconds. 
8. It was important to ensure that the Sepharose beads were attached to the filters after 
washing. This was done by inspection by eye. 
Figure 2.8: Filling of the work station containers 
(PyroMark Q24 User Guide). 
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9. The filters were held above the PyroMark plate while the vacuum was turned off. The 
filters were then lowered onto the plate and the tool was shaken for 30 seconds to 
release the beads. 
10. The tool was placed in container 4 and shaken for 10 seconds. 
11. The vacuum was turned on and the tool was washed twice with dH2O (70 ml). 
12. When finished, the tool was placed in the parking position. 
 
2.8.4 Attachment of sequencing primers to the samples 
1. The PyroMark Q24 plate was incubated for 2 minutes at 80 °C. 
2. The samples were left to cool down for 5 minutes at room temperature. 
 
2.8.5 Preparation of PyroMark Q24 Gold Reagents and pyrosequencing 
1. The freeze-dried enzyme and substrate (PyroMark Q24 Gold Reagents) were added 
filtrated water (620 µl) and left to dissolve for at least 10 minutes. 
2. Enzyme, substrate and nucleotides were added to the PyroMark Q24 cartridge 
according to the Pre Run Information report. 
3. The cartridge was then placed in the PyroMark Q24 sequencing instrument, along 
with the PyroMark Q24 plate. 
4. The run file was uploaded and the sequencing procedure was initiated. 
5. After the run the container was cleaned thoroughly and a pressure-test was performed 
to ensure that the needles in the bottom were not blocked. 
The pyrosequencing procedure is presented by the manufacturer in this video: 
http://www.labtube.tv/channel.aspx?v=137486&u=QIAGEN.  
 
2.8.6 Analysis of results 
The results were presented as pyrograms in PyroMark Q24 2.0.6.20 (figure 2.9). The software 
calculated the methylation percentage for each CpG site in the four different assays. The light 
signal is proportional to each incorporated nucleotide. Percentage methylation in CpG sites is 
calculated as the ratio of the signal height for methylated cytosine divided by the sum of the 
signal height of methylated and unmethylated cytosines. The methylation percentages were 
given a colour code based on the quality assessments for the variable position. According to 
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the PyroMark Q24, blue represent approved, yellow indicates approved, but under doubt and 
red indicates not approved. The instrument do the assessments based on how well the signals 
corresponds to the average signal from the reference sequence. We have chosen to present all 
data, with reservations that red coloured data points need to be inspected carefully. Blue and 
yellow are both considered reliable, and red are not considered in the analysis. Data from the 
pyrograms are represented as a graph where the methylation percentage is shown. 
 
 
2.9 Statistical Methods 
Statistical analysis was done using SigmaPlot 12.3 and p<0.05 was accepted as statistically 
significant. Comparison of multiple groups was performed using one-way ANOVA followed 
by post-hoc tests to identify which groups that differed from each other. One-way ANOVA 
followed by Holm-Sidak test was used on normal distributed data, and data that were not 
normal distributed was analysed using one-way ANOVA on Ranks followed by Dunn’s test. 
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B5: TYGTAGGYGTTTTYGGGGAGTATYGTTAGGYGATATTGGATTGAATTTYGTAYGTATTTTAGTTAGGGATTTAGGTTT
Figure 2.9: A pyrogram represented in PyroMark Q24 2.0.6.20. This is the result from 
FOXA1_pyro2 assay with DNA from HBEC-2KT-CSC.L. Peak height relates to the number of 
nucleotides incorporated Y represents C/T ratio. The analysis results are shown above each CpG 
site (blue background colour) and the colour around the percentage represents the quality of the 
analysis. Blue denotes approved. The sequence to be analysed is shown at the top. The bisulfite 
treatment controls are marked with yellow background colour. 
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3 Results 
3.1 Transformed cell lines 
The cell lines used for this study are HBEC derived cell lines exposed to various components 
present in cigarette smoke (B[a]P, CSC and MNU) for 12 weeks and selected two times in 
soft agar. HBECs exposed to DMSO for 7 weeks were used as control, as these were the only 
available control cells. HBEC control cells were also exposed to DMSO for 12 weeks 
followed by isolation of RNA and DNA and subsequent testing in soft agar, which resulted in 
no growth. Unfortunately, these control cells were not preserved for further experiments. An 
overview of the cell lines is presented in table 1.3. 
 
3.2 Soft agar assay 
HBEC-12KT control cells (DMSO) and untreated HBEC-12KT were tested for colony 
formation in soft agar. No anchorage-independent growth was observed for either cell lines. 
Colony formation was observed for the positive control (tumour cell line A549) (figure 3.1). 
 
 
3.3 Cell migration assay 
Cell migration is an important process for all living cells, especially during development and 
wound healing. This process is also essential for progression and metastasis of cancer cells. 
 
Two methods for studying cell migration were used in this thesis. Both involved the same 
basic procedure; make a wound in the cell monolayer, monitor wound-healing progression by 
Figure 3.1: A549 colonies in soft agar stained with crystal violet. 
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light microscope and capture images after a chosen time course. This was followed by 
calculation of migration capacity. The first method included the use of IncuCyte ZOOM, and 
is a semi-automated approach. Images were acquired on an hourly basis. The second method 
was an in vitro scratch assay that was performed manually. Images were obtained after 0 and 
12 hours. Following, the images and graphs are presented and at the end the migration data 
from both in vitro scratch assay and IncuCyte ZOOM are summarised (table 3.1). 
 
3.3.1 Cell migration analysis by IncuCyte ZOOM 
IncuCyte ZOOM is a light microscope instrument that acquires images automatically and can 
be placed in an incubator at the laboratory. By using specific ImageLock plates for the 
purpose of migration, images are taken at the exact same spot each time, as the plates have 
reference markers at the bottom, providing points to accurately locate the images. Scratch 
wounds were made using a special tool that ensured uniform wounds in the cell monolayer. 
Cells were seeded at a density of 25 000 cells per well in 96-well plates and grown to 
confluence in the incubator, which usually took about 24 hours.  
 
In the following sections are representative results of the IncuCyte migration assay presented 
by images taken 0, 12 and 24 hours after wounding. Only parallel A from second time in soft 
agar (2A) was used during experiments with IncuCyte ZOOM. Representative videos of 
HBEC-2KT control cells (DMSO), HBEC-2KT-CSC.L, HBEC-12KT control cells (DMSO) 
and HBEC-12KT-CSC.L-B can be found here: http://youtu.be/iZey1Fdq0z8, 
http://youtu.be/cs7vksAyk9E, http://youtu.be/KzgaZ6sQXVA, http://youtu.be/vpqJbVO5X7E 
respectively. Appendix D presents images from all cell lines analysed by IncuCyte ZOOM.  
 
Figure 3.2 represents the cell migration of HBEC-2KT control cells (DMSO) during 24 hours. 
A clean-cut scratch wound (time point 0 hours) was made, by Essen 96-well WoundMaker, in 
the confluent cell monolayer. After 12 hours, HBEC-2KT control cells (DMSO) had almost 
closed the wound and only a few open spaces were seen where the wound originally was 
made. After 24 hours the cells had migrated to a confluent monolayer again. 
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HBEC-2KT-CSC.L showed slower migration than their control cells (DMSO). This is 
illustrated in figure 3.3. Some migration of the cells after 12 hours could be observed. After 
24 hours the cells had practically closed the wound, but the initial location of the wound was 
still noticeable. 
 
Figure 3.4 illustrates migration of HBEC-12KT control cells (DMSO). Here, the wound was 
closed after 12 hours. At this time point, it seems as these cells had migrated to such a high 
extend that they “overpopulated” the wound; it looks like the cells migrated on top of each 
other. After 24 hours the cells were evenly distributed.  
Figure 3.2: Migration of HBEC-2KT control cells (DMSO) 0, 12 and 24 hours after wounding.  
Figure 3.3: Migration of HBEC-2KT-CSC.L 0, 12 and 24 hours after wounding. 
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Figure 3.5 illustrates migration of HBEC-12KT-CSC.L-B. These cells migrated slower 
compared to their control cells (DMSO). After 12 hours the wounding area was reduced in 
size. After 24 hours the wound was still not completely closed. 
 
Migration assay using IncuCyte ZOOM was repeated three times for the majority of the cell 
lines, except for untreated HBECs that were only analysed once. HBEC-12KT-CSC.L-A was 
examined four times. Number of parallels for each experiment is variable. The number of 
experiments and parallels depended on the limited availability of instrument usage, as well as 
errors during the procedure, as for example imperfect wounds and bubbles disrupting the 
calculations done by the instrument, which led to insecure data. All of the experiments for 
each cell line are represented in appendix E and a high degree of consistency can be observed 
Figure 3.4: Migration of HBEC-12KT control cells (DMSO) 0, 12 and 24 hours after wounding. 
Figure 3.5: Migration of HBEC-12KT-CSC.L-B 0 hours, 12 hours and 24 hours after wounding. 
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between the independent experiments. One representative was chosen for each cell line in the 
following presentations. Visual inspection of the overall trend of the data was used to decide 
which parallels were to be included in analyses. An example of this process is shown in 
appendix F. 
 
In figure 3.6, migration percentage during 24 hours is represented as relative wound density 
as a function of time (0-24 hours). Untreated HBEC-3KT closed the wound significantly 
faster than HBEC-2KT and HBEC-12KT 12 hours after wounding (p<0.050, one-way 
ANOVA with Holm-Sidak post test). Untreated HBEC-2KT and HBEC-12KT showed 
similar migration values. 
 
 
When comparing time courses for HBEC-2KT derived cell lines from the in vitro 
transformation experiment, the control cells (DMSO) migrated above 100 % from 13 to 24 
hours (figure 3.7). This was due to the calculation method used and is further explained in 
section 4.1.1. Untreated HBEC-2KT, HBEC-2KT-CSC.L and HBEC-2KT-CSC.H showed 
similar time courses and all had a significantly slower migration compared to control cells 
(DMSO) 12 hours after wounding (p<0.05, one-way ANOVA with Holm-Sidak post test). 
Figure 3.6: Relative wound density (%) of untreated HBEC-2KT, HBEC-3KT and HBEC-12KT 
over a time course of 24 hours. HBEC-2KT is denoted by blue circles, HBEC-3KT by blue 
triangles and HBEC-12KT by red squares. During the time period between 15 and 16 hours after 
initiation of the experiment the instrument had to reboot and hence lack of data points. Number of 
parallels (n) is denoted at the end of each curve. Error bars denote SD for each data point. 
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HBEC-12KT control cells (DMSO) showed a significantly faster migration compared to some 
of the transformed cells (B[a]P.L, B[a]P.H, CSC.L-A and CSC.L-B) 12 hours after wounding 
(p<0.05, one-way ANOVA on Ranks with Dunn’s post test). However, control cells (DMSO) 
did not show a significantly faster migration compared to HBEC-12KT-CSC.H, HBEC-
12KT-MNU and untreated HBEC-12KT 12 hours after wounding (figure 3.8). All of the 
transformed cell lines displayed similar migration patterns, but the figure may indicate 
somewhat faster wound closure of for example HBEC-12KT-CSC.H compared to HBEC-
12KT-CSC.L.  
Figure 3.7: Relative wound density (%) of HBEC-2KT and its transformed cell lines over a time 
course of 24 hours. Blue circles denote untreated cells and blue triangles denote control cells 
(DMSO). Transformed cell lines are denoted by pink triangles and red squares, low dose CSC 
and high dose CSC respectively. During the time period between 15 and 16 hours after initiation 
of the experiment the instrument had to reboot and hence lack of data points. Number of 
parallels (n) is denoted at the end of each curve. Error bars denote SD for each data point. 
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3.3.2 In vitro scratch assay 
Cells were seeded at a density of 5x105 cells/well in 6-well plates for the manually in vitro 
scratch assay and incubated for two till three days until a confluent monolayer was formed. 
The majority of cell lines were seeded in three wells within each experiment and three 
scratches were made in each well (a total of nine scratches). Six scratches were included in 
the calculations (n=6), due to errors during the experiment, as open spaces in the monolayer 
and debris in the wounding area. Cells originating from HBEC-2KT-CSC.H-2D and HBEC-
12KT-CSC.L-B were seeded in only one well (n=3). This was one of the first experiments 
performed (where cells were only seeded in one well), and as they showed an overall 
consistency they were not repeated. Light microscopy images were acquired at time point 0 
hours (immediately after the wounds were made) and after 12 hours incubation. The 
migration data were analysed and representative results are depicted below. 
 
HBEC-2KT control cells (DMSO) showed some migration 12 hours after wounding (figure 
3.9). HBEC-2KT-CSC.L (figure 3.10) migrated faster than its control cells (DMSO) during 
12 hours incubation. 
Figure 3.8: Relative wound density (%) of HBEC-12KT and its transformed cell lines over 
a time course of 24 hours. Blue circles denote untreated cells and blue triangles denote 
control cells (DMSO). Transformed cell lines are denoted by pink triangles, beige crosses, 
red squares, grey circles, blue green crosses and green squares; low dose CSC colony A and 
B, high dose CSC, low dose and high doses B[a]P and MNU respectively. During the time 
period between 15 and 16 hours after initiation of the experiment the instrument had to 
reboot and hence lack of data points. Number of parallels (n) is denoted at the end of each 
curve. Error bars denote SD for each data point. 
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Figure 3.9: Migration of HBEC-2KT control (DMSO) cells 0 and 12 hours 
after wounding. At the top are images acquired with a light microscope (10x 
magnification) and at the bottom are results from the software CellProfiler. 
Different blue colours represent areas covered by cells and black corresponds to 
open spaces. 
Figure 3.10: Migration of HBEC-2KT-CSC.L 0 and 12 hours after wounding. 
At the top are images acquired with a light microscope (10x magnification) and 
at the bottom are results from the software CellProfiler. Different blue colours 
represent areas covered by cells and black corresponds to open spaces. 
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HBEC-12KT control cells (DMSO) had entirely closed the wound 12 hours after wounding, 
and the wounding area appeared clearly oversaturated (figure 3.11). A monolayer of cells 
outside the wounding area could clearly be observed, but the CellProfiler software mistakenly 
analysed it as no cells; hence it became black. Thus, by visual inspection of the images it was 
concluded that HBEC-12KT control cells (DMSO) had completely closed the wound 12 hours 
after wounding. HBEC-12KT-CSC.L-B apparently migrated at a slower rate compared to its 
control cells (DMSO). There was some evidence of migration, as figure 3.12 shows, but not 
complete closure of the wound during the 12-hour duration of the experiment. 
 
 
Figure 3.11: Migration of HBEC-12KT control cells (DMSO) 0 and 12 hours 
after wounding. At the top are images acquired with a light microscope (10x 
magnification) and at the bottom are results from the software CellProfiler. 
Different blue colours represent areas covered by cells and black corresponds to 
open spaces. 
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Migration percentages were calculated from data obtained by CellProfiler according to the 
formula in section 2.7.2. Area occupied by cells was subtracted from total area (area occupied 
by cells and area not occupied by cells) to obtain uncovered area, at 0 hours and 12 hours 
after wounding. By using the wound area at 0 hours as a reference, the migration percentage 
for each cell line was determined by calculating the percentage cell coverage in the wounding 
area 12 hours after wounding. 
 
Figure 3.13 shows that untreated HBEC-2KT showed a significantly higher migration 
percentage than both untreated HBEC-3KT and HBEC-12KT 12 hours after wounding 
(p<0.05, one-way ANOVA with Holm-Sidak post test). Untreated HBEC-12KT also showed 
a significantly higher migration percentage than untreated HBEC-3KT 12 hours after 
wounding (p<0.05, one-way ANOVA with Holm-Sidak post test).  
Figure 3.12: Migration of HBEC-12KT-CSC.L_B 0 and 12 hours after 
wounding. At the top are images acquired with a light microscope (10x 
magnification) and at the bottom are results from the software CellProfiler. 
Different blue colours represent areas covered by cells and black corresponds 
to open spaces. 
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Four colonies of each of the transformed cell lines were analysed by in vitro scratch assay 
(2A, 2B, 2C and 2D). These represent four different colonies after the second selection in soft 
agar. In this case, when analysing results from the in vitro scratch assay the mean migration 
percentage was calculated for each of the colonies (2A-2D), resulting in one value for each 
colony. This gives four values used to represent the percentage migration of that transformed 
cell line. 
 
Untreated HBEC-2KT and its transformed cells had similar percentage migration 12 hours 
after wounding. In contrast, HBEC-2KT control cells (DMSO) showed a significantly slower 
migration 12 hours after wounding than the transformed cells (p<0.05, one-way ANOVA 
with Holm-Sidak post test) (figure 3.14). This is in contradictory to results obtained from 
IncuCyte ZOOM. Cells transformed with low dose CSC showed about 35 % increased 
migration, and those transformed with high dose of CSC about 20 % when analysed by in 
vitro scratch assay. 
 
Figure 3.13: Percentage migration of untreated HBEC-2KT, 
HBEC-3KT and HBEC-12KT 12 hours after wounding. Standard 
deviation is shown above the bars. Number of parallels is 6 for 
HBEC-2KT and HBEC-12KT, and 4 for HBEC-3KT. One-way 
ANOVA with Holm-Sidak post test was performed (p<0.05). 
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In figure 3.15 it can be seen that by transforming HBEC-12KT with various doses of CSC, 
B[a]P and MNU the migration capacity decreased significant to varying degrees compared 
with the control cells (DMSO) 12 hours after wounding (p<0.05, one-way ANOVA with 
Holm-Sidak post test). High doses B[a]P repressed the migration significantly (approximately 
90 %) compared with the other transformed cells. Low dose of CSC reduced migration with 
approximately 40 % as observed in colony A and approximately 70 % as observed in colony 
B. High dose of CSC and MNU repressed the migration with near 50 %, and low dose B[a]P 
reduced the migration with approximately 40 %. Untreated HBEC-12KT migrated close to 30 
% after 12 hours. 
Figure 3.14: Percentage migration of HBEC-2KT control cells (DMSO), untreated cells and its 
transformed cells (CSC.L and CSC.H) 12 hours after wounding. Standard deviation is shown 
above the bars. Number of parallels is 6 for DMSO and untreated cells, and 4 for transformed 
cell lines. One-way ANOVA with Holm-Sidak post test was performed and the following p-
values are marked: p<0.05=*, p<0.01=**, p<0.001=***.  
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Table 3.1 summarises the migration data acquired from both in vitro scratch assay and 
IncuCyte ZOOM. The migration percentages analysed by in vitro scratch assay is represented 
after 12 hours, whereas results from the migration analysis by IncuCyte ZOOM are 
represented after both 12 and 24 hours. In the comparisons of the two methods, the focus is on 
12 hours after initial wounding. As mentioned above, migration percentages from in vitro 
scratch assay were calculated from the mean of the four colonies (2A-2D) after second 
selection in soft agar. However, migration results from IncuCyte ZOOM only include colony 
2A. The in vitro scratch assay showed an overall similar migration percentage for all the 
colonies within each exposure group, and therefore colony 2A was chosen to represent the 
transformed cell lines during experiments with IncuCyte ZOOM. This was done due to the 
large amount of data that would be obtained and the time given to work with the instrument.  
 
Overall, great consistency was observed between migration percentages analysed by the two 
different methods (table 3.1). Untreated HBEC-2KT and transformed cells displayed in 
general similar migration percentages. However, regarding HBEC-2KT control cells (DMSO) 
there was a clear difference in migration percentage measured across the methods, from 32 % 
migration obtained by in vitro scratch assay and CellProfiler till 98 % migration calculated by 
Figure 3.15: Percentage migration of HBEC-12KT control cells (DMSO), untreated cells and 
its transformed cells (CSC.L-A , CSC.L-B, CSC.H, B[a]P.L, B[a]P.H and MNU) 12 hours 
after wounding. Standard deviation is shown above the bars. Number of parallels is 3 for 
DMSO, 6 for untreated cells, and 4 for transformed cell lines. One-way ANOVA with Holm-
Sidak post test was performed and the following p-values are marked: p<0.05=*, p<0.01=**, 
p<0.001=***. 
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the integrated software in IncuCyte ZOOM. Untreated HBEC-3KT also varied in migration 
percentage; 17 % migration was obtained by in vitro scratch assay and CellProfiler versus 74 
% measured by IncuCyte ZOOM’s integrated software. Among HBEC-12KT derived cells 
the migration percentages for untreated cells and two of the transformed cells (CSC.L-A and 
B[a]P.H) varied most between the two methods. Regarding the other transformed cells, there 
was an overall consistency. 
  
Table 3.1: Migration (%) of the HBEC control cells (DMSO), untreated cells and their transformed 
cells. Results from in vitro scratch assay 12 hours after wounding and migration assay using IncuCyte 
ZOOM 12 and 24 hours after wounding. 
 
Cell lines 
Migration (%) 
In vitro scratch assay IncuCyte ZOOM 
12h 12h 24h 
Untreated HBEC-2KT 62 50 90 
HBEC-2KT control cells (DMSO) 32 98 100 
HBEC-2KT-CSC.L  67 60 88 
HBEC-2KT-CSC.H 53 41 80 
    
Untreated HBEC-3KT 17 74 100 
    
Untreated HBEC-12KT 33 52 85 
HBEC-12KT control cells (DMSO) 100 86 100 
HBEC-12KT-CSC.L-A 62 39 76 
HBEC-12KT-CSC.L-B 32 42 82 
HBEC-12KT-CSC.H 49 60 99 
HBEC-12KT-B[a]P.L 61 49 91 
HBEC-12KT-B[a]P.H 13 48 86 
HBEC-12KT-MNU 53 58 85 
 
The width of the wounds for the in vitro scratch assay varied from 1.5-3.3 mm. Results from 
the migration images obtained by IncuCyte ZOOM showed a wound width of approximately 
0.7 mm. 
 
3.4 DNA methylation assay 
DNA methylation is essential in normal development in mammals. It is an epigenetic 
modification, and changes may alter the expression of genes and this has been associated with 
cancer. Pyrosequencing is a quantitative method of DNA sequencing and was used to 
examine DNA methylation levels in this thesis. Previous studies showed that expression of 
the FOXA1 and FOXA2 genes was significantly downregulated in transformed cell lines of 
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both HBEC-2KT and HBEC-12KT. The subject for this part of the thesis was to examine if 
altered FOXA expression could be explained by changes in DNA methylation of the genes. 
 
3.4.1 Assay design 
A total of four assays were used during the pyrosequencing procedure, designed by Audun 
Bersaas; engineer at STAMI. Two assays in the FOXA1 gene (FOXA1_pyro1 and 
FOXA2_pyro2) and two assays in the FOXA2 gene (FOXA2_cpg1 and FOXA2_TSS) were 
designed. Figure 3.16 shows the localisation of the assays in the genes, along with promoter, 
exons, CpG islands, primer pairs and position of transcription start site. Details about the 
assay designs are discussed in section 4.1.3. 
 
 
 
The number of CpG sites examined by the different assays was: FOXA1_pyro1; 12 CpG 
sites, FOXA1_pyro2 and FOXA2_cpg1; 7 CpG sites and FOXA2_TSS; 20 CpG sites. 
 
3.4.2 Pyrosequencing 
The bisulfite treatment and pyrosequencing procedure was repeated twice for the majority of 
the cell lines with the exception of methylase-treated DNA that was only performed once, and 
HBEC-2KT-CSC.L-2C (FOXA2_cpg1 and FOXA2_TSS) that was repeated three times. 
There was observed an overall good consistency between the independent experiments.  
 
Figure 3.16: Localisation of assays on the FOXA1 and FOXA2 genes, along 
with promoter, exons, CpG islands, primer pairs and position of transcription 
start site. 
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In the following section, results of the pyrosequencing analysis are presented. Data points are 
represented by colour codes as determined by the PyroMark Q24 software. Blue data points 
characterise approved data, but is in this study represented by individual colours on the graphs 
(purple, green or black) to differentiate between experiments. Yellow points represent that 
percentage methylation of the specific CpG site was approved under doubt and red points 
when not approved by the software. The software does the quality assessment based on how 
well the signals correspond to the average signal from the reference sequence. In this thesis, 
all data are included in the graphs. Unless otherwise stated red points were left out of the 
analysis, whereas blue and yellow were both considered approved and reliable. This is based 
on previous experiences with pyrosequencing analysis at STAMI. 
 
Pyrosequencing results from methylase-treated DNA 
DNA treated with the enzyme methylase was used as a positive control for the procedure 
(figure 3.17). DNA isolated from HBEC-2KT-CSC.L-2A was treated with methylase and 
included in the pyrosequencing experiments (this was the same positive control used by a 
fellow master student performing methyl-DNA immunoprecipitation (MeDIP)). There was 
observed an overall trend of high methylation, ranging from 90-100 %, at the different CpG 
sites, except for CpG 11 (44 %) in FOXA1_pyro1 (red point) and CpG 7 (80 %) in 
FOXA1_pyro2 (red point) assays. Also, in both FOXA2 assays there was observed an overall 
trend of high methylation percentages at the different CpG sites, except for some, which are 
considerably lower. In FOXA2_cpg1 assay CpG 3 (28 %) was remarkably lower than the 
other CpG sites. In FOXA2_TSS assay CpG’s 1, 2, 10 and 15-17 were below 50 % and lower 
than the other CpG sites examined in this assay. This experiment has only been performed 
once, and should be repeated to confirm the results. In FOXA1_pyro1 at CpG 11 the software 
informs that the signals do not correspond to the reference sequence. For FOXA2_TSS, the 
same reasons were given for the red points, and in addition, the CpG’s from 15-20 have high 
sum deviation in the variable positions. FOXA1_pyro2 and FOXA2_cpg1 assay was 
unsuccessful due to a notation of failed bisulfite conversion.  
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Pyrosequencing results from HBEC-2KT derived cell lines 
HBEC-2KT control cells (DMSO) (figure 3.18) showed an overall high methylation in all of 
the CpG sites in FOXA1_pyro1 assay ranging from 70-100 %, with the same decrease at CpG 
11 as methylase-treated DNA. This particular site is not reliable due to red points in two 
repeated measurements. HBEC-2KT cells exposed to a low dose CSC (figures 3.19-3.22) 
showed varying degrees of methylation across the FOXA1_pyro1 CpG sites examined. 
Overall, the majority of the methylation percentages ranged between 35-90 %. There was a 
tendency towards lower methylation at CpG 4 (10-15 %) and 9 (15-25 %, except parallel 2A), 
and partly 8 (10-20 %) in 2B and 2D. These cells also showed lower methylation at CpG 11 
compared with CpG sites close by. CpG 11 was a red data point for some of the parallels, as 
in many of the later analysis. HBEC-2KT exposed to a high dose CSC (figure 3.23) showed a 
general methylation percentage ranging from 70-100 % at CpG sites 1-5, 7 and 12 in 
FOXA1_pyro1 and 50 % methylation and below at CpG’s 6 and 8-11. 
 
In the FOXA1_pyro2 assay HBEC-2KT control cells (DMSO) (figure 3.18) and its 
transformed cells (figures 3.19-3.23) showed an overall high degree of methylation ranging 
from 80-100 %. All showed a tendency toward lower methylation in CpG 7 compared to 
Figure 3.17: Methylation percentage in CpG sites in methylase-treated DNA (from HBEC-
2KT-CSC.L-2A), across FOXA1 (top) and FOXA2 (bottom) genes. The location of the 
different assays is depicted in figure 3.16. PyroMark Q24 defines yellow squares as 
approved under doubt and red means the data is not approved. Blue is defined as approved 
and is here represented as the colour of the graph: purple. 
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adjacent CpG sites. This was considered reliable in 9 out of 12 experiments with HBEC-2KT 
derived cell lines. HBEC-2KT-CSC.L showed methylation of approximately 70 % in CpG 4. 
CpG’s 1 and 3 in HBEC-2KT-CSC.H also showed a trace of decreased methylation 
percentage in the range of 70-75 %. They were all considered reliable. 
 
FOXA2_cpg1 assay showed an overall methylation below 10 % for transformed HBEC-2KT 
cell lines (figures 3.19-3.23) and the control cells (figure 3.18). There was a tendency toward 
increased methylation at CpG 6 to varying degrees compared with the overall methylation 
degree in the assay, expect one of the experiments with HBEC-2KT-CSC.H. The indicated 
increased methylation was considered reliable in 9 of 11 experiments. In HBEC-2KT-CSC.L-
2D all of the sites were marked red and interpreted by PyroMark Q24 software as failed 
bisulfite conversion. 
 
In the FOXA2_TSS assay there was an overall very low methylation percentage among 
HBEC-2KT control cells (DMSO) (figure 3.18) and transformed cells (figures 3.19-3.23), 
ranging from 0-30 % for control cells (DMSO) and cells exposed to low dose CSC. In 
contrast, cells exposed to high dose CSC had methylation varying from 0-50 %. Control cells 
(DMSO) showed a tendency to increased migration at the last CpG sites, but this cannot be 
considered valid due to red data points (CpG’s 13-20) (some signals do not correlate with the 
references and also in some CpG sites there is high sum deviation in the variable position). 
Thus, in all of the following analysis, only the CpG’s 1-12 were considered reliable in the 
analysis of FOXA2_TSS CpG sites. HBEC-2KT-CSC.L-2A showed a methylation of 
approximately 15 % at CpG 5 compared to methylation below 10 % for adjacent CpG’s. CpG 
6 in HBEC-2KT-CSC.L-2C showed a methylation of 26 %, but this is not considered reliable 
due to that two repeated experiments show 1-3 % methylation in the same CpG site. HBEC-
2KT-CSC.H showed methylation varying from 0-36 % across the FOXA2_TSS assay. In 
CpG’s 2 and 7 an increased methylation compared to adjacent CpG’s was shown. 
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Figure 3.18: Methylation percentage in CpG sites in HBEC-2KT control cells 
(DMSO) across FOXA1 (top) and FOXA2 (bottom) genes. The location of the 
different assays is depicted in figure 3.16. The green and purple lines represent two 
independent bisulfite/pyrosequencing experiments on the same DNA sample. Yellow 
squares mean that the data from pyrosequencing are approved under doubt and red 
means the data is not approved. Blue is defined as approved and is here represented 
as the colour of the graphs: green and purple. 
Figure 3.19: Methylation percentage in CpG sites in HBEC-2KT-CSC.L-2A across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
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Figure 3.20: Methylation percentage in CpG sites in HBEC-2KT-CSC.L-2B across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
 
Figure 3.21: Methylation percentage in CpG sites in HBEC-2KT-CSC.L-2C across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green, purple and black lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green, purple and black. 
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Figure 3.22: Methylation percentage in CpG sites in HBEC-2KT-CSC.L-2D across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
 
Figure 3.23: Methylation percentage in CpG sites in HBEC-2KT-CSC.H across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares 
mean that the data from pyrosequencing are approved under doubt and red means 
the data is not approved. Blue is defined as approved and is here represented as the 
colour of the graphs: green and purple. 
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Pyrosequencing results from HBEC-12KT derived cell lines 
HBEC-12KT control cells (DMSO) (figure 3.24) and transformed cells (figures 3.25-3.33) 
also showed a high methylation percentage in the FOXA1_pyro1 assay, ranging from 70-100 
%, except in HBEC-12KT-B[a]P.L where one of the experiments showed overall lower 
migration percentages than the other experiments. As for HBEC-2KT derived cell lines, all of 
the HBEC-12KT derived cell lines also show a lower methylation of about 50-55 % at CpG 
11 (red point). HBEC-12KT control cells (DMSO), HBEC-12KT-CSC.L-A (figure 3.25), 
HBEC-12KT-CSC.H (figure 3.30), HBEC-12KT-B[a]P.L (figure 3.31) and HBEC-12KT-
B[a]P.H (figure 3.32) all showed a tendency of decreased methylation at CpG 9. This is 
considered a valid data point as set by the PyroMark Q24 software.  
 
FOXA1_pyro2 assay showed an overall methylation of 90-100 % in all of the transformed 
HBEC-12KT cell lines and their control cells (DMSO). At CpG 7 there was a tendency of 
decreased methylation to about 70-75 % for both control cells (DMSO) and transformed cells.  
 
There was observed low levels of DNA methylation of all the transformed HBEC-12KT cell 
lines and their control cells (DMSO) in the FOXA2_cpg1 assay, ranging from 0-6 %. In 
addition, there was a tendency toward higher methylation in some of the sites, as CpG 3 in 
control cells (DMSO), CpG 6 in HBEC-12KT-CSC.L-B (3.26-3.29), HBEC-12KT-B[a]P.H 
and HBEC-12KT-MNU (one of the experiments), and CpG 2 in HBEC-12KT-CSC.H (though 
not valid in one of the parallels). These represented only a minor increase compared with the 
overall methylation. 
 
The FOXA2_TSS assay showed fluctuating methylation across the CpG sites studied in 
HBEC-12KT control cells (DMSO) and their transformed cells. As for HBEC-2KT derived 
cell lines, there were also red data points at CpG’s 13-20 in this assay for HBEC-12KT 
derived cell lines. Thus, in all of the following analysis of HBEC-12KT derived cell lines, 
only the CpG’s 1-12 were considered in the analysis. The majority of the HBEC-12KT 
transformed cells lied at the same level as the control cells (DMSO), ranging from 20-50 % 
methylation. CpG 11 analysed in HBEC-12KT-CSC.L-B-2A, -2B and -2D showed above 70 
% methylation. The same cell line’s parallels 2A, 2B and 2C show methylation below 10 % at 
the first three CpG sites, and also CpG 4 in parallel 2A. Parallel 2D showed below 10 % 
methylation at CpG 3. HBEC-12KT-CSC.H also showed methylation below 10 % at CpG’s 1, 
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2, 4 and 5. HBEC-12KT-B[a]P.L showed methylation below 10 % at CpG’s 1, 2, 4 and one 
experiment in CpG 11, and HBEC-12KT-B[a]P.H at CpG’s 1-4.  
 
HBEC-12KT transformed with MNU (figure 3.34) showed different overall methylation 
percentage from the two independent experiments in the FOXA2_TSS assay; the results from 
the first experiment indicated about 20 % overall methylation, however there was red points 
at CpG’s 4-12 due to that signals did not correlate with the reference. Results from the second 
experiment ranged from 30-45 % methylation. There seemed to be a tendency towards lower 
methylation at CpG’s 1, 2 (in the first experiment), 3, 9, 11 and 12 compared to the other 
CpG’s. 
 
 
Figure 3.24: Methylation percentage in CpG sites in HBEC-12KT control cells 
(DMSO) across FOXA1 (top) and FOXA2 (bottom) genes. The location of the 
different assays is depicted in figure 3.16. The green and purple lines represent two 
independent bisulfite/pyrosequencing experiments on the same DNA sample. Yellow 
squares mean that the data from pyrosequencing are approved under doubt and red 
means the data is not approved. Blue is defined as approved and is here represented 
as the colour of the graphs: green and purple. 
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Figure 3.25: Methylation percentage in CpG sites in HBEC-12KT-CSC.L-A across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares 
mean that the data from pyrosequencing are approved under doubt and red means the 
data is not approved. Blue is defined as approved and is here represented as the colour 
of the graphs: green and purple. 
 
Figure 3.26: Methylation percentage in CpG sites in HBEC-12KT-CSC.L-B-2A across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
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Figure 3.27: Methylation percentage in CpG sites in HBEC-12KT-CSC.L-B-2B across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
 
Figure 3.28: Methylation percentage in CpG sites in HBEC-12KT-CSC.L-B-2C across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
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Figure 3.29: Methylation percentage in CpG sites in HBEC-12KT-CSC.L-B-2D across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is depicted 
in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is not 
approved. Blue is defined as approved and is here represented as the colour of the graphs: 
green and purple. 
 
Figure 3.30: Methylation percentage in CpG sites in HBEC-12KT-CSC.H across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
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Figure 3.31: Methylation percentage in CpG sites in HBEC-12KT-B[a]P.L across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares 
mean that the data from pyrosequencing are approved under doubt and red means the 
data is not approved. Blue is defined as approved and is here represented as the colour 
of the graphs: green and purple. 
 
Figure 3.32: Methylation percentage in CpG sites in HBEC-12KT-B[a]P.H across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares mean 
that the data from pyrosequencing are approved under doubt and red means the data is 
not approved. Blue is defined as approved and is here represented as the colour of the 
graphs: green and purple. 
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To summarise the results, CpG 11 in FOXA1_pyro1 showed generally lower percentage 
methylation compared with the other CpG sites in that assay. However, CpG 11 in 
FOXA1_pyro1 was in general a red point, so according to PyroMark Q24 this was not valid. 
Further, FOXA1_pyro1 showed generally higher percentage methylation in both HBEC-
12KT control cells (DMSO) and transformed cells, compared to HBEC-2KT derived cells 
where it was more fluctuating in methylation percentages. FOXA1_pyro2 assay generally 
showed a high degree of DNA methylation for all of the cell lines studied. In the CpG sites of 
FOXA2_cpg1 assay there was an overall low degree of DNA methylation in all the 
transformed HBEC-2KT and transformed HBEC-12KT, and their control cells (DMSO). This 
also applied to FOXA2_TSS in HBEC-2KT control cells (DMSO) and transformed cells. 
HBEC-12KT control cells (DMSO) and transformed cells showed more fluctuating 
methylation percentages in CpG sites in the FOXA2_TSS assay. Thus, no outstanding 
changes in DNA methylation were observed between non-transformed and transformed cell 
lines in the CpG sites studied. 
Figure 3.33: Methylation percentage in CpG sites in HBEC-12KT-MNU across 
FOXA1 (top) and FOXA2 (bottom) genes. The location of the different assays is 
depicted in figure 3.16. The green and purple lines represent two independent 
bisulfite/pyrosequencing experiments on the same DNA sample. Yellow squares 
mean that the data from pyrosequencing are approved under doubt and red means the 
data is not approved. Blue is defined as approved and is here represented as the colour 
of the graphs: green and purple. 
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4 Discussion 
The aim of this study was to investigate characteristics of in vitro transformed HBEC derived 
cell lines to look into how various carcinogens can affect the cells migration capability and if 
methylation of CpG islands in the FOXA1 and FOXA2 genes might be able to explain their 
observed downregulation. 
 
Immortalized HBEC derived cell lines used during this study are valuable tools for studying 
the multistage pathogenesis of lung cancer, and they offer several advantages. Especially the 
ability to genetically modify the cell lines, and study genetic and epigenetic alterations in lung 
cancer is invaluable. Also, immortalized cell lines do not have a finite replication potential as 
normal cells, due to shortening of telomeres, senescence and cell cycle arrest. The 
immortalized cells do not exhibit independent growth in soft agar, as studies show in section 
3.2. In addition, the HBECs maintain an intact p53 checkpoint and stability of the genome is 
preserved (Gazdar et al., 2010; Ramirez et al., 2004). 
 
However, there are limitations to using cell line models. It is important to keep in mind that 
genetic instability, selective growth advantages and lack of interaction with non-tumour 
components might influence the cell lines. Nevertheless, if cell lines with unlimited lifespan 
were not available, the knowledge of lung cancer would be much less advanced. It is 
important to keep in mind factors affecting the model, such as how well it resembles the 
original tumour, driver mutations and acquired differentiated properties during long term 
passage. Then, data can be interpreted from in vitro studies concerning lung pathogenesis 
(Gazdar et al., 2010). 
 
4.1 Discussion of methods 
4.1.1 Cell migration 
Two methods have been used to study cell migration in this thesis: the manual in vitro scratch 
assay and a semi-automated technique using IncuCyte ZOOM. In vitro scratch assay is 
commonly chosen as method for cell migration analysis, due to its advantages: easy set-up 
and materials needed are available in any laboratory performing cell culturing. In addition the 
method does to some extend mimic the migration of cells in vivo (Liang et al., 2007). Here, 
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cells were seeded at a density of 5x105 cells per well in a 6-well plate until a confluent layer 
of cells was formed. The wound was made using a pipette tip, and it was ensured that images 
were obtained from the exact same spot at 0 and 12 hours after wounding. Manually 
wounding with a pipette tip makes it challenging to ensure the same width of the wounds in 
every trial. Width of the wounds varied from approximately 1.3-3.3 mm. After images were 
achieved they were retouched to eliminate debris in the wound area. There are no indications 
that variations in wound width affected the results, as some cells with a wider wound in the 
cell monolayer showed higher migration percentages than some cells with a narrower wound, 
and conversely. 
 
The CellProfiler software was used to analyse cell migration data acquired from the manual in 
vitro scratch assay. To develop a suitable pipeline for the purpose of the study, different 
algorithms were tested by trial and error approach. The fully developed pipeline is presented 
in appendix C. After image analysis and data processing the results obtained were inspected 
by eye to ensure the functioning of the pipeline. For example, migration percentages from 
HBEC-12KT control cells (DMSO) were ambiguous. A confluent layer of cells could be 
observed from the cell images (figure 3.11), but the software analysed some of it as no cells. 
An oversaturation of cells in the wound area appears to have occurred showing a higher cell 
density in the middle, which contributes to a higher intensity. As speckles (areas of increased 
intensity in relation to its immediate neighbourhood) were chosen as the features to identify in 
the CellProfiler software, the area surrounding the oversaturated wound was not included as 
“features”, as it had lower intensity. 
 
The assay could be improved by the use of alternative softwares for data processing, as 
CellProfiler mainly relies on image brightness (Glaß et al., 2012). 
 
Cell migration was also analysed using the instrument IncuCyte ZOOM, which represents a 
semi-automated migration analysis. The method used is an extension and improvement of the 
scratch wound assay (Nelson et al., s.a.). One advantage of this method is the 96-well 
WoundMaker that creates smooth wounds of equal size. In addition there are markers at the 
ImageLock plates from Essen Biosciences, ensuring accurate imaging. Another advantage is 
that there is no need for retouching of images in the same way as with the in vitro scratch 
assay. Furthermore, the instrument automatically acquires images at set time intervals and 
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IncuCyte’s integrated software enables quantification of the migration percentage straight 
after images have been acquired and gives opportunities for on-going analysis. 
 
Migration above 100 % was observed for some cell lines. This might be due to the calculation 
method used. As mentioned in section 2.7.1, when using RWD, cell density in the wound area 
is measured relative to the cell density outside the wound area. But some cell lines, as for 
example HBEC-2KT control cells (DMSO), oversaturation of cells were observed in the 
wound area, together with small open spaces in the cell monolayer outside the wound area. 
Hence, the cell density inside the wound was greater than the cell density outside the wound, 
and hence migration percentages above 100 % were calculated. 
 
Disadvantages with the use of IncuCyte ZOOM that might cause downstream errors in the 
results were experiences. Instrumental errors, such as rebooting of the instrument for various 
reasons caused lack of data points. Also, during wound making, the WoundMaker sometimes 
introduced errors by imperfect wounds. Care had to be taken to avoid air bubbles during 
washing procedures and addition of fresh media, as they were difficult to remove and might 
have affected the results in a negative way. 
 
4.1.2 DNA methylation analysis 
Existing methods for analysis of DNA methylation have advantages and disadvantages. For 
example, the desired precision (quantitative versus qualitative data), screening or in depth 
analysis, number of samples and DNA quality and quantity will influence the choice of 
technique. The methods vary in accuracy, sensitivity, reproducibility and types of bias (Dahl 
and Guldberg, 2003; Laird, 2010). 
 
In this study, bisulfite treatment of DNA followed by pyrosequencing was the method of 
choice. Bisulfite sequencing has been rendered the most trustworthy method when it comes to 
identification of methylated cytosines in any sequence (Laird, 2010). Methods involving 
bisulfite treatment of DNA tends to be fairly accurate and reproducible. Compared with 
analyses using restriction endonucleases, methods relying on bisulphite treatment possess 
several advantages. Most importantly, the methylation status can be determined of virtually 
any CpG site in the genome. However, some sources of error exist, as incomplete bisulfite 
conversion of unmethylated cytosine to uracil, which may arise from incomplete denaturation 
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before bisulfite treatment or reannealing during conversion. To reduce the risk of reannealing 
the bisulfite reaction can be done in a thermocycler with repeated steps of heating. Besides 
that, overtreatment with bisulfite may degrade DNA, due to partial acid-catalysed 
depurination, and also lead to increased incidence of methylated cytosines converted to uracil. 
This will result in under-reporting of the methylation percentage. The incubation time also 
influences damage to template sequences. Four hour incubation with bisulfite has been 
reported to be sufficient for complete conversion (Dahl and Guldberg, 2003; Laird, 2010). 
 
Bisulfite-treated DNA can be used directly in a standard PCR reaction and further sequence-
analysed by for example pyrosequencing. Uracil (represent unmethylated cytosine) and 
thymine will be amplified as thymine, whereas 5’-methylcytosine will be amplified as 
cytosine (Dahl and Guldberg, 2003). The PCR procedure can be improved in various ways; 
one approach is by increasing the annealing temperature of the PCR reaction. After DNA has 
been bisulfite-treated, methylated DNA has a higher content of guanine and cytosine than 
unmethylated DNA, and this can favour secondary structures as hairpins (Shen et al., 2007). 
Sequence analysis of PCR products after bisulfite treatment is considered the gold standard 
for gene-specific methylation providing information about the methylation status of every 
cytosine within the target sequence (Dahl and Guldberg, 2003). Pyrosequencing can be used 
for quantitative determination of both global DNA methylation and gene-specific analyses. 
 
Restriction endonucleases, with different sensitivity to cytosine methylation, can be used to 
study methylation changes within their recognition site. Methylation of specific cytosines will 
render the DNA sequence insensitive to cleavage by one enzyme, but not the other. Usually 
the enzymes HpaII/MspI are used, where both enzymes cleave CCGG sites, but only MspI 
cleaves if internal cytosine is methylated. This makes these enzymes valuable tools for rapid 
DNA methylation analyses. When amplifying by PCR only the methylated sequence will 
result in PCR products. This method is suitable for a large number of samples, due to its 
simplicity, low cost and ease of interpretation. Limitations might be that this method only 
provides information about CpG’s within the cleavage site, furthermore, there is a risk of false 
positives due to incomplete digestion (Dahl and Guldberg, 2003; Oakeley, 1999). Several 
techniques have now been developed whose strategy is to interact directly with methylated 
DNA. A simple approach based on direct immunoprecipitation of methylated DNA has been 
developed (MeDIP) where monoclonal antibodies against 5’-methylcytosine are used to 
purify methylated DNA. The methylation status can be further studied by the use of specific 
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primers for the desired gene section followed by PCR. This method of analysis is excellent 
when there are regions with high CpG density, as in CpG islands. In contrast, when analysing 
promoters low in CpG dinucleotides this technique may not be suitable (Jacinto et al., 2008). 
 
Methylation-specific PCR takes benefit of the bisulfite-induced sequence difference in 
bisulfite-treated DNA. It is a widely used technique to investigate methylation status in 
specific CpG sites. Nevertheless, information obtained from this technique should be further 
validated by quantitative methods, and therefore methylation-specific PCR is best suited as a 
rapid technique to initially screen samples for methylation of specific genes (Dahl and 
Guldberg, 2003). 
 
In the future, nanopore sequencing might be the next revolution in high-throughput DNA 
methylation analysis, and will eliminate the need for bisulfite treatment by offering a potential 
for direct sequencing of 5’-methylcytosine in DNA (Laird, 2010).  
 
4.1.3 Assay design for pyrosequencing 
Two assays in both the FOXA1 gene (FOXA1_pyro1 and FOXA2_pyro2, figure 3.16) and the 
FOXA2 gene (FOXA2_cpg1 and FOXA2_TSS, figure 3.16) were designed for this study. The 
regions were chosen in accordance with ENCODE, taken into account especially results from 
earlier methylation studies in various cell lines and the binding of transcription factors (figure 
4.1 and 4.2). Further, a fellow master student at STAMI worked with MeDIP in a parallel 
thesis and we wanted the pyrosequencing assay to lie in the same areas so that the two 
approaches of examining DNA methylation could be compared. This was obtained for 
FOXA1_pyro1 and both FOXA2 assays. It was important to optimize the PCR conditions to 
ensure specific PCR products, especially the annealing temperature. For FOXA1_pyro1 and 
FOXA2_cpg1 the annealing step was set to 60 °C, whereas for FOXA1_pyro2 and 
FOXA2_TSS the temperature was 58.5 °C. The assays for the FOXA1 gene are located 
upstream of the gene, possibly in an enhancer region (figure 4.1).  
 
 
 90 
 
 
FOXA1_pyro1 is located within a CpG island and there is proof of methylation in this area in 
A549 (human lung adenocarcinoma epithelial cell line), HepG2 (liver hepatocellular 
Figure 4.1: Localisation of FOXA1_pyro1 (red oval) and FOXA1_pyro2 (blue oval) assays 
represented by data from ENCODE (the gene, transcription levels, CpG islands (dark green lines), 
histone methylations, histone acetylation, methylation levels and transcription factor binding sites 
(grey)) is shown in A. In B there are zoomed in on the localisations of the assays. Both assays are 
located upstream of the gene. FOXA1_pyro1 is localized in a CpG island, whereas FOXA1_pyro2 
is not. DNA methylation is represented by red (100 % of molecule sequences are methylated), 
yellow (50 %) or green (0 %).  
 91 
carcinoma cells), MCF-7 (human breast adenocarcinoma cells) and LNCaP (lymph node 
carcinoma of the prostate). Thus, we wanted to examine this area in HBEC derived cell lines 
as well. FOXA1_pyro2 is not located in a CpG island, but by considering data from 
ENCODE, hypermethylation in this region has been reported for the cell lines A549, HeLa-S3 
(human epithelial carcinoma cell line), HepG2 and MCF-7. Also, results indicate some 
methylation in LNCaP. Further, several transcription factor binding sites are shown to be 
located in this area via chromatin immunoprecipitation (ChIP) analyses. In both of the areas 
where the assays are located, normal breast and lung cells show no methylation, indicating 
that there might be a difference between cancer cells and normal cells. 
 
Assays for the FOXA2 gene also lie upstream of the gene (figure 4.2). FOXA2_cpg1 is 
located in a CpG island and there is several transcription factor binding sites in this area 
according to ENCODE data (figure 4.2). No methylation analyses are represented here in 
ENCODE. FOXA2_TSS is located immediately upstream of the gene in the promoter and is 
in a CpG island. According to ENCODE there is some indication of methylation in MCF-7 
and many transcription factor binding sites (ChIP analyses). For the FOXA2_TSS assay, data 
from Basseres et al. (2012) was also considered. Results from this study indicated methylated 
CpG dinucleotides in various lung cancer cell lines in CpG’s located in the area of the 
promoter. 
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Figure 4.2: Localisation of FOXA2_cpg1 (red oval) and FOXA2_TSS (blue oval) assays 
represented by data from ENCODE (the gene, transcription levels, CpG islands (dark green 
lines), histone methylations, histone acetylation, methylation levels and transcription factor 
binding sites (grey)) is shown in A. In B there are zoomed in on the localisations of the assays. 
FOXA2_cpg1 is located upstream of the gene in a CpG island, whereas FOXA2_TSS lies 
around the promoter and also within a CpG island. DNA methylation is represented by red 
(100 % of molecule sequences are methylated), yellow (50 %) or green (0 %). 
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4.2 Discussion of results 
Transformed cell lines (two from HBEC-2KT and six from HBEC-12KT) were established 
prior to this study. The cells had been exposed to various carcinogens over a time course of up 
to 15 weeks, followed by selection of colonies in soft agar. Hence, observed effects are results 
of earlier exposures that might have led to development of new, stable phenotypes. In 
addition, gene expression differences are expected to occur, which might be at least partly due 
to epigenetic mechanisms. Thus, methylation studies were conducted to investigate whether 
DNA methylation had a role in altered expression of the FOXA1 and FOXA2 genes in 
transformed cell lines. 
 
Anchorage independent growth is an indication of carcinogen-induced transformation, and is 
confirmed by growth in soft agar. HBEC-12KT control cells (DMSO) and untreated HBEC-
12KT did not form colonies in soft agar, which was also expected from earlier tests in our 
laboratory. HBEC-2KT control cells (DMSO) and untreated HBEC-2KT did not form 
colonies in soft agar either, as confirmed by earlier experiments (Damiani et al., 2008; 
Sjøberg, 2012). The soft agar assay selects for cells with acquired heritable changes, which 
would facilitate growth in the absence of attachment to a surface on the petri dish or flask 
(Freshney, 1987).  
 
4.2.1 Cell migration 
Cell migration is an important mechanism for tumour cells. By studying in vitro wound 
healing of transformed cells versus non-transformed cells one can get insight into how cell 
migration capacities are affected by various carcinogens. Untreated HBECs showed different 
migration characteristics across the two methods used to study cell migration. According to 
results by IncuCyte ZOOM, untreated HBEC-3KT migrated faster than untreated HBEC-2KT 
and untreated HBEC-12KT, the ladder two showing similar migration. Results from in vitro 
scratch assay indicated that untreated HBEC-2KT migrated faster than both untreated HBEC-
3KT and untreated HBEC-12KT. The migration assays with untreated HBECs have only been 
done once, so this needs to be repeated to be able to draw solid conclusions. The HBECs 
originate from different donors, thus their gene expression profiles may vary due to different 
genetic and epigenetic factors. However, all the untreated HBECs show relatively high 
migration compared with transformed HBEC derived cell lines. This might be due to 
additives in the media, such as L-glutamine and serum. L-glutamine has been documented to 
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play an essential role during cell proliferation and enhance the function of immune cells. In 
addition L-glutamine is important during injury, and creating a wound in the cell monolayer 
mimics the healing process during for example injury, as the cells migrate to close the wound 
(Newsholme, 2001). Serum contains TGF-β, which might have a role in cell migration and 
invasion as changes in the microenvironment upon its activity favour cell migration and 
capillary formation (Derynck et al., 2001). TGF-β is also known to induce EMT, which again 
is involved in cell migration (Tang et al., 2011). Untreated HBECs were grown in serum-free 
media, so TGF-β cannot trigger their migration. However, control cells (DMSO) and 
transformed cells are grown in media supplemented with serum, which might contribute to 
their observed migration. Control cells (DMSO) tend to have a more rapid migration than 
untreated HBECs, which might indicate that TGF-β in serum may be related to the observed 
increased migration. 
 
Transformed HBEC-2KT derived cell lines closed the wound approximately halfway during 
the 12-hour observation period, as was observed by both methods. HBEC-2KT control cells 
(DMSO) showed higher migration than the transformed cells when analysed by IncuCyte 
ZOOM, which is in contrast to data obtained from in vitro scratch assay, where migration by 
HBEC-2KT control cells (DMSO) apparently was much slower compared to transformed cell 
lines. However, these migration assays on HBEC-2KT control cells (DMSO) were only 
carried out once by in vitro scratch assay and thus it will be necessary to repeat the 
experiments on these cells to be able to draw solid conclusions. Also, due to equivocal results 
from the two migration analysis methods, further studies are needed to explain these results. 
HBEC-12KT control cells (DMSO) showed a more rapid migration compared to its 
transformed cell lines. Transformation of HBEC-12KT seemed to decrease the migration to 
varying degrees, as determined by both methods. Overall, the migration percentages of the 
HBEC-12KT transformed cells were in the range between 30-60 %. Migration of control cells 
(DMSO) was in the range between 85-100 %. 
 
EMT is indicated to be a process in the development of cancer cells due to the acquired 
potential of invasion and metastasis. In a study from 2007, B[a]P was shown to induce EMT-
related gene expression in A549 cells, which lead to a migratory phenotype (Yoshino et al., 
2007). Previous short-time exposure studies indicated that higher concentrations of CSC 
inhibited wound closure in primary bronchial epithelial cells, whereas exposure to lower 
concentrations of CSC resulted in a significant increase in wound closure (Luppi et al., 2005). 
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A recent study indicated that CSC might silence the expression of genes involved in 
downregulation of EMT, which is characterised by increased cell migration (Veljkovic et al., 
2011). It can, however, not be excluded that the observed changes in migration capacity 
among transformed cell lines in the present study also might be related to the selection 
process in soft agar. In addition, in our laboratory we have tested five different in vitro 
transformed cell lines (HBEC-2KT-CSC.L-2A, HBEC-2KT-CSC.H-2A, HBEC-12KT-
CSC.L-A-2A, HBEC-12KT-CSC.H-2A, HBEC-12KT-B[a]P.H-2A) for growth in nude mice 
by subcutaneous injection (six mice per cell line).  The mice have now been observed for five 
months and there are no signs on formation of tumours. This is in accordance with Damiani et 
al. (2008), and indicates that additional genetic and epigenetic alterations are required to 
facilitate tumour formation. 
 
The transcription factors FOXA1 and FOXA2 are considered to be involved in 
carcinogenesis. Changes in their gene expression were observed with carcinogen-induced 
transformation. Thus, in previous experiments at STAMI the expression of several genes were 
observed to be altered upon transformation with B[a]P, CSC and MNU. A significant 
downregulation of FOXA1, FOXA2 and CDH1 genes was found in transformed cells 
compared to their control cells (DMSO). Contrary, an upregulation of the CDH2 gene in 
transformed cells compared to its control cells (DMSO) was found. Downregulation of the 
FOXA1 and FOXA2 genes might indicate EMT. This includes hallmarks as gain of 
mesenchymal phenotype and increased migration. In addition, a switch from E-cadherin 
(CDH1 gene) to N-cadherin (CDH2 gene) is characteristic for EMT. The process of EMT is 
closely related to cancer progression, and has been observed in NSCLC (Byers et al., 2013; 
Guarino et al., 2007). 
 
A observed change in phenotype from rounded, epithelial form of non-transformed cells to a 
more elongated shape of transformed cells was observed, consistent with EMT. However, our 
results did not confirm any increase in migration in the transformed cell lines compared to 
control cells (DMSO), except for in HBEC-2KT derived cell lines analysed by in vitro scratch 
wound. This suggests that not only EMT contributes to cell migration and also that 
transformation is not only dependent on EMT. Thus, other genetic and epigenetic changes 
might have been taking place in the transformed cell lines contributing to their overall 
diminished migration percentage compared to non-transformed cells. It is, however, clear that 
cell migration and EMT are not directly linked in this in vitro transformation model. 
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Oversaturation was observed for some cell lines during cell migration assays. This might 
indicate loss of contact inhibition, which is also observed in various types of cancer cells. 
Merlin is a protein that couples cell-surface adhesion molecules, as E-cadherin, to 
transmembrane receptor tyrosine kinases, as epidermal growth factor receptor. Hence, the 
adhesiveness of cadherin-mediated intercellular attachments is strengthened. In addition, 
Merlin sequesters growth factor receptors and limits their release of mitogenic signals 
(Hanahan and Weinberg, 2011). Oversaturation may also indicate that communication 
capabilities of the cells are lagging behind. Components of gap junctions are shown to induce 
cell contact growth inhibition via cell communication. Recent studies imply EMT-mediated 
loss of contact inhibition in hepatocarcinoma cells, indicating that cancer cells have the ability 
of oversaturation (Ke et al., 2008). 
 
4.2.2 DNA methylation 
Epigenetic mechanisms have been shown to be involved in carcinogenesis and DNA 
methylation analysis was carried out to study if hypermethylation was associated with the 
observed downregulation of the FOXA1 and FOXA2 genes in transformed cell lines. In the 
FOXA1_pyro1 assay, overall highly methylated DNA (above 70 %) was observed in 
transformed HBEC-12KT cell lines and their control cells (DMSO). However, DNA from 
HBEC-2KT derived cell lines showed varying methylation percentages in the CpG sites in 
this assay. Control cells (DMSO) and HBEC-2KT exposed to high dose CSC showed higher 
overall methylation than HBEC-2KT transformed by low dose CSC, where there in general 
was observed approximately 50 % methylation. However, HBEC-12KT-CSC.H showed a 
drop in DNA methylation in CpG’s 8-11. 
 
The CpG’s studied in the FOXA1_pyro2 assay showed an overall high degree of methylation, 
above 70 %, in both transformed cell lines (HBEC-2KT and HBEC-12KT) and their control 
cells (DMSO). Methylation in both of the FOXA1 regions studied has been indicated by 
previous studies in carcinoma cell lines as A549, HeLa-S3 (only in FOXA1_pyro2), HepG2 
and MCF-7 (ENCODE). Correspondingly, methylation studies in normal breast and lung cells 
do not indicate methylation in these CpG sites. This suggests a difference between normal and 
carcinoma cell lines in the degree of methylation. However, in this study, control cells 
(DMSO) from both HBEC-2KT and HBEC-12KT derived cell lines showed an overall high 
 97 
CpG methylation in FOXA1. Thus, it is difficult to draw conclusion on whether the measured 
methylation levels are responsible for the observed downregulation of FOXA1. In addition, it 
cannot be deduced whether DNA methylation is a result of transformation as non-transformed 
cell lines already had high methylation levels in the studied CpG sites. 
 
An overall low DNA methylation was observed in FOXA2_cpg1 assay for both transformed 
cell lines (HBEC-2KT and HBEC-12KT) and their control cells (DMSO). According to 
ENCODE, no methylation data for this region has been reported yet. The CpG sites studied in 
the FOXA2_TSS assay in DNA from both transformed HBEC-2KT and control cells 
(DMSO) showed overall methylation levels below 50 %. DNA from transformed HBEC-
12KT and their control cells (DMSO) showed overall methylation levels between 20-50 % in 
the FOXA2_TSS assay. For HBEC-12KT-CSC.L-B, more than 70 % methylation in three of 
four colonies was observed in CpG 11 of the FOXA2_TSS assay. This might contribute to the 
observed downregulation of FOXA2 in the cell line, as this increase in methylation was not 
observed in the control cells (DMSO). In this region methylation has been observed in MCF-7 
cells (ENCODE). However, only minor or no DNA methylation in A549 and HepG2 has been 
observed. FOXA2 gene expression was downregulated despite no outstanding differences in 
DNA methylation between transformed and non-transformed cells. Thus, it might be 
speculated that DNA methylation in the inspected sites are not involved in gene silencing. In 
addition, there are many factors contributing to the regulation of gene expression, as 
transcription factors, miRNA, cell signalling, mRNA splicing and degradation (Chen and 
Rajewsky, 2007). Several studies indicate that hypermethylation at CpG islands in promoter 
has important roles in the progression of cancer and it is considered to be a common hallmark 
of many types of cancer. Methylation at CpG islands may lead to repression of normal 
functions (Esteller, 2007). It was found that the FOXA2 gene was methylated in two out of 
five transformed cell lines (Damiani et al., 2008). A study from 2012 showed that 48 % of the 
studied NSCLC cell lines had more than 10 % CpG dinucleotide hypermethylation in the 
FOXA2 promoter, and an inverse correlation between absence of FOXA2 mRNA or FOXA2 
protein and degree of hypermethylation was observed (Basseres et al., 2012). 
 
Generally, for the FOXA2_TSS assay there was red colour code for CpG’s 13-20 after 
analyses by the PyroMark Q24 software, and thus, these data points were not considered in 
the analyses. The instrument does a quality assessment and gives the CpG’s a colour code, as 
explained in section 2.10.6. Red indicates that the data are not approved. When inspecting the 
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results in the PyroMark Q24 software the red points at CpG’s 13-20 was due to signals that 
did not correlate with the expected references. Also, high sum deviation in the variable 
position was observed in some CpG sites. This might be related to incorrect incorporation of 
bases by DNA polymerase, due to the length of this assay (337 bp’s). According to the 
PyroMark PCR Handbook (2009) amplicons for CpG assays should ideally be shorter than 
200 bp’s. The amplicons for FOXA1_pyro1 and FOXA2_cpg1 were also longer than 200 
base pairs (264 and 251 bp’s, respectively), but in those cases that did not appear to interfere 
significantly with the quality of the data. An obvious further improvement would be to design 
a new sequencing primer situated a couple of CpG sites before CpG 13 in the FOXA2-TSS 
assay to be able to study DNA methylation levels in the remaining part of the region. This 
work is ongoing in the lab. 
 
In the present study, the whole procedure of bisulfite treatment of DNA followed by 
pyrosequencing for quantification of DNA methylation was repeated twice on all samples. 
Overall, a high degree of consistency between the data from the two independent analyses 
was observed. 
 
In a parallel master thesis MeDIP was used to assess the degree of methylation in the FOXA1 
and FOXA2 genes. In general, experiments with MeDIP resulted in overall lower methylation 
percentages compared with results obtained by pyrosequencing. Theoretically, there can be 
various reasons for the observed difference between the methods. First, it might be due to 
failed bisulfite treatment. However, this appears not to be the case in this present study as 
controls for bisulfite conversion are included and insufficient conversion would have resulted 
in red colour code. Second, differences could have been due to overtreatment with bisulfite. 
However, this would have lead to DNA damage and reduced or no PCR products, so this is 
also not a likely explanation for the differences across the two methods. Last, it might be 
related to positioning of the primers. Assays for FOXA1_pyro1 and FOXA1_C1 (MeDIP) 
overlap, so a big difference in methylation percentages would not be expected. However, 
FOXA1_pyro1 indicated high methylation as observed from pyrosequencing results, and this 
area also stood out in MeDIP analyses. This might indicate that the CpG’s studied in 
FOXA1_pyro1 has higher methylation than the other CpG’s examined. 
 
The FOXA2_cpg1 assay is located close to the FOXA2_C1 assay (MeDIP) and they are 
placed in the same CpG island. The FOXA2_TSS assay is located in the same CpG island as 
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the FOXA2_C3 assay (MeDIP). Hence, similar results could have been expected. Results 
from pyrosequencing showed an overall lower methylation in the CpG sites within FOXA2 
compared with FOXA1. Results from MeDIP analyses indicated higher methylation in the 
FOXA2_C1 assay compared to other CpG regions. In the FOXA2_cpg1 assay analysed by 
pyrosequencing results indicated less than 10 % DNA methylation in this area, which was 
lower than other CpG’s studied. Only HBEC-2KT-CSC.L-2B showed higher levels of 
methylation in the FOXA2_C3 assay compared to the other cell lines. Results from 
pyrosequencing in FOXA2_TSS indicated low DNA methylation for all the studies cell lines. 
It might be difficult to compare pyrosequencing and MeDIP considering methylation levels, 
as MeDIP results showed rather low methylation values. It is, along with MeDIP results, 
difficult to draw any conclusions for alterations in methylation between transformed and non-
transformed cell lines. This is rather unexpected especially regarding FOXA2, as Basseres et 
al. (2012) presented results suggesting that DNA methylation is correlated with 
downregulation of FOXA2 in lung tumours. 
 
4.2.3 Future work 
For future work, it would be interesting to perform gene expression analyses of DNMTs in the 
HBEC derived cell lines. DNMT1 has shown to be overexpressed in several cancers, 
including lung. Also, DNMT3a and 3b have shown to be overexpressed in tumours, and 
cooperates with DNMT1 (Damiani et al., 2008). Furthermore, it would be interesting to 
investigate whether cell adhesion genes are methylated during carcinogen-induced 
transformation of HBEC derived cell lines used in this study. Methylation of for example E-
cadherin has been observed in bronchial epithelial cells from smokers. Consequently, 
demethylation strategies might improve primary cancer prevention in smokers (Damiani et 
al., 2008). 
 
Additionally, it could be relevant to go into more detail about what other factors than DNA 
methylation that can contribute to alterations in expression of the FOXA1 and FOXA2 genes 
in the HBEC derived cell lines. Subjects of such studies could be transcription factors, cell 
signalling and microRNAs. 
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5 Conclusion 
The aims of this study were to investigate mechanisms involved in development of lung 
cancer. The first aim was to investigate how in vitro transformation by tobacco smoke 
carcinogens affected cell migration, and the second aim was to investigate whether DNA 
methylation could explain the downregulation of the FOXA1 and FOXA2 genes in 
transformed cell lines.  
 
Cell migration was shown to both decrease and increase in transformed cell lines relative to 
its control cells (DMSO). Two methods were used to study cell migration: the manual in vitro 
scratch assay and a semi-automated technique using IncuCyte ZOOM. However, it is clear 
that cell migration and EMT are not directly linked in this in vitro transformation model even 
though previous gene expression analyses indicated cadherin switch. Nevertheless, 
transformation of HBECs with tobacco-related carcinogens was shown to induce changes in 
cell migration. 
 
It might be speculated that the inspected sites in the FOXA1 gene not are involved in gene 
silencing since control cells express the gene despite high levels of methylation. Further, no 
outstanding alterations in DNA methylation in CpG sites were detected between non-
transformed and transformed cell lines. Consequently, it cannot be concluded whether DNA 
methylation caused the observed downregulation of the FOXA1 and FOXA2 genes in this in 
vitro transformation model.  
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A. Materials 
In the following tables is information regarding instruments (A.1), materials (A.2), cell 
culture media (A.3), chemicals (A.4), solutions (A.5), kits (A.6) and computer software (A.7) 
used during the work with this thesis. 
 
Instruments 
Table A.1: Instruments and their labels that were used in this thesis. 
Instrument Name/label 
Agitator Thermolyne Speci-Mix, Sybron, Thermolyne 
Autoclave Systec DX-90 
Cell Counter Countess Automated Cell Counter, 
Invitrogen 
Centrifuges Eppendorf Centrifuge 5702 
Sigma 2-6E 
Thermo Scientific MicroCL21 
VWR Galaxy Mini 
Centrifuges (Cooler) Eppendorf Centrifuge 5417R 
Sigma 4K15 
Heating Blocks Grand Instruments QBT2 
Eppendorf Thermomixer Comfort 
Imaging System Bio-Doc® 220 Imaging System, Benchtop 
UV Transilluminator, UVP 
Incubator Thermo Forma 
Binder 
IncuCyte ZOOM Essen BioScience 
Microscope Nikon Diaphoto light microscope 
PyroMark Q24 Qiagen 
PyroMark Q24 Vacuum Station Qiagen 
Spectrophotometer Eppendorf Biophotometer 
NanoDrop 8000 Spectrophotometer 
Thermal Cyclers (cDNA and PCR) Perkin Elmer Cetus DNA Cycler 480 
Techne TC-3000X 
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MJ Research, PTC-200, Peltier Thermal 
Cycler 
MJ Research, DNA Engine Dyad, Peltier 
Thermal Cycler 
Vacuum Pump 2511 Dry Vacuum Pump/Compressor, Welch 
Vacuum Station (Bisulfite procedure) Promega 
Vortex Heidolphreax 2000 
Whirlmixer Fision 
Water bath GFL (Gesellschaft für Labortechnik m.b.H) 
 
Materials 
Table A.2: Materials that were used in this thesis. 
Materials Manufacturer 
100 mm dishes NUNC, Nunclon surface sterile 
96- and 6-well plates NUNC, Nunclon surface sterile 
96-Well ImageLock Plates Essen BioScience 
96-Well WoundMaker Essen BioScience 
12 ml, 50 ml Falcontubes Falcon 
Cell Counter chamber slides Invitrogen 
Container for electrophoresis 2012 Maxiphor, Electrophoresis Unit, LKB 
Bromma 
DNA LoBind tubes (2 ml) Eppendorf Tubes 
Electronic Pipettes Pipetboy, Integra Biosciences 
Pipetus®-akku, Hirschmann Laborgerate 
Gilson 
Flat 8 Cap Strips Thermo Scientific 
Gel electrophoresis chambers BioRad 
Lid with wires (electrophoresis) BioRad 
Microsentrifuge tubes (0.5, 1.5 ml) Trefflab 
Multichannel Pipette Micronic Systems 
PCR plates Thermo Scientific 
Plastic film for 96-well plate MicroAmp, Applied Biosystems 
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Plastic Pipettes VWR 
PyroMark Q24 Plate Qiagen 
PyroMark Q24 Cartridge Qiagen 
Quarts kuvettes QS-Hellma 
Sterile filter Pall Corporation, Acrodisc Syringe filters 
Twist top vials, with cap Sorensen Bioscience Inc. 
Volt Source Gene Power Supply GPS 200/400, 
Pharmacia 
 
Cell Culture Media 
Table A.3: Cell culture media that were used in the thesis, including additives, manufacturer and 
catalogue number. 
Medium Additives Manufacturer Catalogue 
no. 
GIBCO® LHC-9 Serum-free 
medium 
 
L-glutamine, serum-free, 
phenol red 
Invitrogen 12680-013 
GIBCO® DMEM/F-12 15 mM HEPES buffer, 
L-glutamine 
Invitrogen 11039-021 
 
Chemicals 
Table A.4: Chemicals used in this thesis, their manufacturer and catalogue number. 
Chemical Manufacturer  Catalogue 
no. 
100 bp DNA ladder New England Biolabs  3231S 
Acrylamide Bio-Rad  161-0146 
Ammonium acetate BDH  100124T 
Benzo(a)pyrene (B[a]P) Sigma Aldrich  B-1760-1G 
Buffer EB (elution buffer) Qiagen  19086 
Chloroform Sigma Aldrich  C2432 
Cigarette smoke condensate (CSC) Murty Pharmaceuticals   
Collagen (PureCol) Advanced BioMatrix  5005B 
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Crystal Violet Sigma Aldrich  C3886 
Difco Agar Noble BD  214220 
Dimethylsulfoxide (DMSO) Koch Licht  2228-00 
EDTA Fluka Biochemika  03690 
Ethanol (rectified, absolute) Kemethyl  600051 
Fetal Bovine Serum (FBS) Gibco  10099-141 
GelRed Biotium Inc.  41003 
HEPES Sigma Aldrich  H9136 
Hydroquinone Sigma Aldrich  H9003 
Loading buffer Sigma Aldrich  G2526 
Sodium hydroxide (NaOH) Sigma Aldrich  S8045 
NuSieve® 3:1 Agarose Lonza  50090 
Phenol red Sigma Aldrich  P3532 
PhiX174 RF DNA Promega  5018402 
Propan-2-ol (isopropanol) Merck  2006617 
PyroMark Annealing Buffer Qiagen  979009 
PyroMark Binding Buffer Qiagen  979006 
PyroMark Denaturation Solution Qiagen  979007 
PyroMark Gold Q24 Reagents Qiagen  970802 
PyroMark Wash Buffer, 10x Qiagen  979008 
SeaKem® GTG® Agarose Lonza  50070 
Sodium Bisulfite, A. C. S reagent Sigma Aldrich  2439739 
Streptavidin Sepharose High Performance GE Healthcare  17-5113-01 
Penicillin Streptomycin Gibco  15 140-114 
Isol-RNA lysis reagent 5’ prime  2302700 
Trizma hydrochloride solution Sigma Aldrich  T3038 
Trypan Blue Stain  Invitrogen  T10282 
Trypsin Sigma Aldrich  T1147 
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Solutions 
All solutions were made with dH2O and solutions for cell culturing were sterile filtered before 
use. 
Table A.5: Solutions. 
Solution Content 
Ammonium acetate (10M) 77 g ammonium acetate, 100 ml dH2O, pH adjusted 
to 7.03, sterile filtered 
Antibiotic freezing (AF) media 76 % L-15 medium, 2 % 1M HEPES, 2 % PS, 20 
% FBS 
Collagen 1 % collagen solution (3.13 mg/ml), 99 % PBS 
DMSO for cell culture storage 50 % L-15 medium, 2 % 1M HEPES, 8 % DMSO, 
40 % FBS 
Ethylenediaminetetraacetic acid 
(EDTA) 
9.3 ml EDTA, 50 ml dH2O, pH adjusted to 8 
FBS Heat inactivated (56 ℃ for 45 minutes) 
HEPES 238.3 g HEPES, 1 ml 0.12 % phenol red in 1 L 
dH2O, pH 7.3 
Phenol red 125 g phenol red. 360 𝜇l 1M NaOH, 100 ml dH2O 
Phosphate Buffered Saline (PBS) 7.07 g NaCl, 0.20 g KCl, 1.94 g NaHPO4*H2O, 
dH2O to 1 L 
TAE buffer (50X) 242 g Tris base, 57.2 ml acetic acid, 100 ml EDTA 
(0.5 M, pH 8.0), dH2O to 1000 ml 
Tris-EDTA (TE) buffer 500 𝜇l 1M Tris pH 8, 10 𝜇l 0.5 M EDTA, dH2O to 
50 ml 
Trypsin (1 %) 50 ml trypsin, 50 ml PBS 
 
Kits 
Table A.6: Kits, their manufacturer and catalogue number. 
Process Kit Name Manufacturer 
(catalogue no.) 
cDNA synthesis qScriptTM cDNA Synthesis 
Kit 
Quanta (95047-500) 
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Genomic DNA isolation Wizard ® Genomic DNA 
Purification Kit 
Promega (A1125) 
DNA purification during 
bisulfite treatment 
Wizard® DNA Clean-Up 
System 
Promega (A7280) 
Pyro-PCR  PyroMark PCR Kit Qiagen (978703) 
 
Computer Software 
Table A.7: Computer software used during this thesis, including their function and manufacturer.  
Function  Software Manufacturer Location 
Assay design for RT-
qPCR 
 SDS Software 2.4  Applied 
Biosystems 
Carlsbad, 
California, USA 
Data analysis  SigmaPlot 12.3 Systat Software 
Inc. 
San Jose, 
California, USA 
IncuCyte ZOOM assay 
design and data analysis 
 IncuCyte ZOOM 
2012A 
Essen 
BioScience 
Ann Arbor, 
Michigan, USA 
Manual analysis of cell 
migration 
 Cell Profiler 2.0 Broad Institute Massachusetts, 
USA 
Pyrosequencing assay 
design and data analysis 
 PyroMark Q24 
2.0.6.20 
Qiagen Hilden, Germany 
Pyrosequencing primer 
design 
 PyroMark Assay 
Design 2.0 
Qiagen Hilden, Germany 
Writing and data 
analysis 
 Microsoft Office 
2007/2011 Excel 
and Word 
Microsoft 
Corporation 
Redmond, 
Washington, USA 
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B. General cell culture work 
 
Thawing of cells 
1. Cells were taken from a nitrogen tank at STAMI, and the ampoule was thawed in a 
water bath (37 °C). 
2. The cells were transferred to a centrifuge tube and LHC-9 medium (5 ml) was added 
3. The vial was centrifuged (1000 rpm, 4 minutes). 
4. The supernatant was discarded and the pellet was re-suspended in medium (3 ml). 
5. Cell suspension was transferred to a petri dish (100 mm), with added medium (5 ml) 
to make a total of 8 ml. 
6. The cells were incubated at 37 °C. 
 
Passaging cells 
1. The media over the cells was removed. 
2. Washed twice with PBS (10 ml). 
3. Trypsin (1 ml) was added to the plates. 
4. The cells were incubated (37 °C) until detachment from the petri dish, this was 
monitored in a light microscope. 
5. Medium was added (5 ml) and the cells were washed up and down for separation of 
cells and washing of petri dish. 
6. The cell suspension was transferred to a centrifuge tube and centrifuged (1000 rpm, 4 
minutes). 
7. The supernatant was discarded. 
8. The pellet was re-suspended in medium (volume depended on dilution) and 
transferred to a 100 mm petri dish, with added medium to make a total volume of 8 
ml. 
9. The cells were incubated at 37 °C. 
 
Freezing of cells 
Followed passaging cells to point 7. 
1. Cells were re-suspended in AF media (500 µl) and transferred to a twist top vial. 
2. DMSO freezing medium (500 µl) was added and the solution was mixed. 
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3. The ampoule was placed in an isolated box at -80 °C for 4-6 hours or overnight. 
4. The ampoule was further placed in a nitrogen tank for long-term storage. 
 
Collagen coating of petri dished 
1. PureCol was diluted in PBS to a total concentration of 0.03 mg/ml. 
2. Collagen was added to 100 mm petri dishes (3 ml), to each well in 6-well plates (1 ml) 
and 96-well plates (100 µl) to completely cover the dishes/wells. 
3. Incubated in the LAF-bench (room temperature) for minimum 2 hours. 
4. The collagen solution was removed and washed twice with PBS. 
Placed the dishes in the freezer (-80 °C). 
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C. CellProfiler pipeline 
A pipeline was developed in CellProfiler to analyse the migration data acquired from the 
manual in vitro scratch assay. Tested different combinations of algorithms to obtain the best-
suited pipeline for these particular experiments.  
First, the images were made into a grey scale; this was necessary for a later 
identification of objects. Edges and certain image features were enhanced to improve 
subsequent identification of the objects, speckles were chosen as the features to enhance. 
Speckles are an area of increased intensity in relation to its immediate neighbourhood and was 
considered to be best suited for this analysis due to increased intensity of cells. Subsequently, 
the image was smoothened to remove artefacts of a particular size. Primary objects could now 
be identified based on the image processing done. In the end, the total image area occupied by 
objects could be measured. This algorithm reports the sum of the areas of the objects defined 
by the identification algorithm. The data was exported to a spreadsheet and further processed 
for presentation of results. 
Below is an overview of the pipeline.  
 
- Load images 
- ColorToGray 
- SaveImages 
- EnhanceOrSuppressFeatures 
- SaveImages 
- EnhanceEdges 
- SaveImages 
- Smooth 
- SaveImages 
- IdentifyPrimaryObjects 
- SaveImages 
- MeasureImageAreaOccupied 
- ExportToSpreadsheet 
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D. Cell images from IncuCyte ZOOM 
Cells were placed in the instrument IncuCyte ZOOM and it was programmed to take images 
on an hourly basis for 24 hours. Images of HBEC derived cell lines 0, 12 and 24 hours after 
wounding are presented below (figure D.1-D.13). 
 
 
 
Figure D.1: Migration of untreated HBEC-2KT 0, 12 and 24 hours after wounding. 
Figure D.2: Migration of HBEC-2KT control cells (DMSO) 0, 12 and 24 hours after 
wounding.  
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Figure D.3: Migration of HBEC-2KT-CSC.L 0, 12 and 24 hours after wounding. 
Figure D.4: Migration of HBEC-2KT-CSC.H 0, 12 and 24 hours after wounding. 
 
Figure D.5: Migration of untreated HBEC-3KT 0, 12 and 24 hours after wounding. 
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Figure D.6: Migration of untreated HBEC-12KT 0, 12 and 24 hours after wounding. 
Figure D.7: Migration of HBEC-12KT control cells (DMSO) 0, 12 and 24 hours after 
wounding. 
Figure D.8: Migration of HBEC-12KT-CSC.L-A 0, 12 and 24 hours after wounding. 
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Figure D.9: Migration of HBEC-12KT-CSC.L –B 0 hours, 12 hours and 24 hours 
after wounding. 
Figure D.10: Migration of HBEC-12KT-CSC.H 0 hours, 12 hours and 24 hours after 
wounding. 
Figure D.11: Migration of HBEC-12KT-B[a]P.L 0 hours, 12 hours and 24 hours 
after wounding. 
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Figure D.12: Migration of HBEC-12KT-B[a]P.H 0 hours, 12 hours and 24 hours 
after wounding. 
Figure D.13: Migration of HBEC-12KT-MNU 0 hours, 12 hours and 24 hours after 
wounding. 
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E. Migration analysis of HBEC derived cell lines using IncuCyte ZOOM 
Migration assay using IncuCyte ZOOM was repeated several times. In the figures E.1-E.10 
below the consistency between the independent experiments of each cell line is noticeable. 
The chosen parallel is marked with a red circle. The parallel chosen is the one that best 
represents the independent migration assays for each cell line. Untreated HBECs (HBEC-
2KT, HBEC-3KT and HBEC-12KT) were only examined once and are not represented here. 
This is due to time pressure and experimental errors. 
 
 
Figure E.1: Three independent migration experiments with HBEC-2KT control cells (DMSO) 
over a time course of 24 hours. Migration is represented as relative wound density (%). The red 
ring denotes the parallel chosen as a representative for the three experiments. 
Figure E.2: Three independent migration experiments with HBEC-2KT-CSC.L over a time course 
of 24 hours. Migration is represented as relative wound density (%). The red ring denotes the 
parallel chosen as a representative for the three experiments. 
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Figure E.3: Three independent migration experiments with HBEC-2KT-CSC.H over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
 
Figure E.4: Three independent migration experiments with HBEC-12KT control cells (DMSO) 
over a time course of 24 hours. Migration is represented as relative wound density (%). The red 
ring denotes the parallel chosen as a representative for the three experiments. 
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Figure E.5: Four independent migration experiments with HBEC-12KT-CSC.L-A over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the four experiments. 
 
Figure E.6: Three independent migration experiments with HBEC-12KT-CSC.L-B over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
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Figure E.7: Three independent migration experiments with HBEC-12KT-CSC.H over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
 
Figure E.8: Three independent migration experiments with HBEC-12KT-B[a]P.L over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
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Figure E.9: Three independent migration experiments with HBEC-12KT-B[a]P.H over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
 
Figure E.10: Three independent migration experiments with HBEC-12KT-MNU over a time 
course of 24 hours. Migration is represented as relative wound density (%). The red ring denotes 
the parallel chosen as a representative for the three experiments. 
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F. Parallels to include in migration analysis by IncuCyte ZOOM 
For various reasons some parallels were left out when analysing data acquired from IncuCyte 
ZOOM. An example can be seen in figure F.1 below, all parallels of HBEC-12KT-CSC.L-B 
and HBEC-2KT-CSC.L show the same overall trend on their graphs. Whereas for HBEC-
12KT, parallels with a red cross clearly deviate from the overall trend, hence they are left out. 
One parallel of HBEC-2KT-CSC.H is missing some data points for some reason. This is an 
instrumental error and the parallel is left out of the calculations. 
 
 
 
 
Figure F.1: Microplate graph from IncuCyte ZOOM. HBEC-12KT control cells (DMSO) is 
represented in red, HBEC-12KT-CSC.L-B in yellow, HBEC-2KT-CSC.L in green and HBEC-
2KT-CSC.H in blue. The red crosses denote the parallels not taken into account, for various 
reasons, during analyses. 
